Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


Articles published in Oral Oncol

Retrieve available abstracts of 637 articles:
HTML format



Single Articles


    December 2022
  1. TAZEEN S, Suri H, Lakshmi R, Subash A, et al
    Swallowing: A delayed milestone post-surgery in tongue cancers.
    Oral Oncol. 2022;135:106238.
    PubMed     Abstract available


  2. TAVERNA F, Alfieri S, Rebecca R, Giulia C, et al
    Comparing BamHI-W and CE-marked assays to detect circulating Epstein-Barr Virus (EBV) DNA of nasopharyngeal cancer patients in a non-endemic area.
    Oral Oncol. 2022;135:106229.
    PubMed     Abstract available


  3. GAO X, Tian K, Huang L, Chen J, et al
    Introducing the thin and ultrathin submental artery perforator flaps for precise reconstruction following T1-2 oral cavity cancer resection.
    Oral Oncol. 2022;135:106234.
    PubMed     Abstract available


  4. SMITH JD, Bellile EL, Ellsperman SE, Heft-Neal ME, et al
    Prognostic value of CD103(+) tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinoma.
    Oral Oncol. 2022;135:106226.
    PubMed     Abstract available


  5. GUNAWARDENA DA, Howes D, Fleming S, Clark J, et al
    Reconstruction of a maxillectomy and rhinectomy defect utilising a novel subperiosteal prosthesis and magnet-retained nasal prosthesis: A case report.
    Oral Oncol. 2022;135:106222.
    PubMed    


  6. MISSALE F, Marchi F, Iandelli A, Subramaniam N, et al
    Oncological outcomes of compartmental surgery and wide local excision in oral tongue and floor of the mouth cancer.
    Oral Oncol. 2022;135:106210.
    PubMed     Abstract available


  7. HENDRIKS T, Flukes S
    Unknown primary Merkel cell carcinoma of the head and neck: Favourable outcomes with definitive radiotherapy.
    Oral Oncol. 2022;135:106228.
    PubMed    


  8. TAZEEN S, Lal R, Kp A, Thakur S, et al
    Molecular and hormonal targets for malignant salivary gland tumors.
    Oral Oncol. 2022;135:106225.
    PubMed    


  9. DE KONING KJ, van Es RJJ, Breimer GE, de Bree R, et al
    Response to: Application of ultrasound-guided resections in surgical removal of squamous cell carcinoma of the tongue.
    Oral Oncol. 2022;135:106199.
    PubMed    


  10. TANG KD, Weeramange CE, Vider J, Hartel G, et al
    Potential use of salivary mRNA-based biomarkers to predict oral squamous cell carcinoma.
    Oral Oncol. 2022;135:106215.
    PubMed    


  11. TAPIA M, Manji J, Dhillon K, Kleid S, et al
    The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection.
    Oral Oncol. 2022;135:106213.
    PubMed     Abstract available


  12. LASSCHE G, van Boxtel W, Aalders TW, van Hooij O, et al
    Development and characterization of patient-derived salivary gland cancer organoid cultures.
    Oral Oncol. 2022;135:106186.
    PubMed     Abstract available


  13. MALI SB
    Epigenetics: Promising journey so far but ways to go in head neck cancer.
    Oral Oncol. 2022;135:106194.
    PubMed     Abstract available


  14. SARAVANAN M
    Constitutive activation of activator protein-1 as a cellular switch and its innovative role in the development of molecular targets for tongue squamous cell carcinoma treatment.
    Oral Oncol. 2022;135:106198.
    PubMed    


  15. KHADEMBASCHI D, Jafri M, Praveen P, Parmar S, et al
    Does neoadjuvant chemotherapy provide a survival benefit in maxillofacial osteosarcoma: A systematic review and pooled analysis.
    Oral Oncol. 2022;135:106133.
    PubMed     Abstract available


  16. PARK BJ, Mattox AK, Clayburgh D, Patel M, et al
    Chemoradiation therapy alters the PD-L1 score in locoregional recurrent squamous cell carcinomas of the head and neck.
    Oral Oncol. 2022;135:106183.
    PubMed     Abstract available


    November 2022
  17. PENG Y, Liu Y, Shen G, Chen Z, et al
    Improved accuracy of auto-segmentation of organs at risk in radiotherapy planning for nasopharyngeal carcinoma based on fully convolutional neural network deep learning.
    Oral Oncol. 2022;136:106261.
    PubMed     Abstract available


  18. MANZOOR H, Rasheed A, Zeen F, Sarfraz A, et al
    Anti-PD-1 immunotherapy - Pembrolizumab current clinical trials for advanced head and neck cancer: A mapping systematic study.
    Oral Oncol. 2022;136:106266.
    PubMed    


  19. LIU HC, Williamson CW, Zou J, Todd JR, et al
    Quantitative prediction of aspiration risk in head and neck cancer patients treated with radiation therapy.
    Oral Oncol. 2022;136:106247.
    PubMed     Abstract available


  20. CHAN JYK, Cheung MK, Lan L, Ng C, et al
    Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes.
    Oral Oncol. 2022;135:106245.
    PubMed     Abstract available


  21. KMIECIK M, Nogal P, Banaszewski J, Wierzbicka M, et al
    Corrigendum to "Anterolateral thigh free flap reconstruction of pharyngoesophageal defect caused by radiotherapy for laryngeal cancer: A case report" [Oral Oncol. 134 (2022) 106135].
    Oral Oncol. 2022 Nov 4:106233. doi: 10.1016/j.oraloncology.2022.106233.
    PubMed    


  22. QUAN T, Guan W, Huang W, Cui C, et al
    Carotid space involvement is a prognostic factor and marker for induction chemotherapy in patients with nasopharyngeal carcinoma.
    Oral Oncol. 2022;135:106230.
    PubMed     Abstract available


  23. BISHESHAR SK, van der Kamp MF, de Ruiter EJ, Ruiter LN, et al
    The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.
    Oral Oncol. 2022;135:106227.
    PubMed     Abstract available


  24. ERRAZQUIN R, Page A, Sunol A, Segrelles C, et al
    Development of a mouse model for spontaneous oral squamous cell carcinoma in Fanconi anemia.
    Oral Oncol. 2022;134:106184.
    PubMed     Abstract available


  25. CHIDAMBARAM S, Hong SA, Simpson MC, Osazuwa-Peters N, et al
    Temporal trends in oropharyngeal cancer incidence, survival, and cancer-directed surgery among elderly Americans.
    Oral Oncol. 2022;134:106132.
    PubMed     Abstract available


  26. AROSIO AD, Bernasconi DP, Valsecchi MG, Pacifico C, et al
    Patterns of recurrences in sinonasal cancers undergoing an endoscopic surgery-based treatment: Results of the MUSES* on 940 patients: *MUlti-institutional collaborative Study on Endoscopically treated Sinonasal cancers.
    Oral Oncol. 2022;134:106123.
    PubMed     Abstract available


  27. CONTRERA KJ, Zafereo ME, Yaniv D, Roberts DB, et al
    Outcomes for recurrent oral cavity squamous cell carcinoma.
    Oral Oncol. 2022;134:106127.
    PubMed     Abstract available


  28. DAS R, Misra SR, Pradhan S
    A simple clinicaapproach to diagnose oral erythroplakia, the potentially malignant disorder with the highest rate of malignant development into squamous cell carcinoma!
    Oral Oncol. 2022;134:106126.
    PubMed    


  29. LIU Y, Bilodeau E, Pollack B, Batmanghelich K, et al
    Automated detection of premalignant oral lesions on whole slide images using convolutional neural networks.
    Oral Oncol. 2022;134:106109.
    PubMed     Abstract available


  30. TITINCHI F, Sallies M, Wu HT
    Mucoepidermoid carcinoma ex pleomorphic adenoma: A rare diagnostically challenging entity.
    Oral Oncol. 2022;134:106112.
    PubMed     Abstract available


  31. RAMASUBBU K, Devi Rajeswari V
    A novel target approach for epithelial-mesenchymal transitioning oral squamous cell carcinoma and their involvement of PI3K/Akt/mTOR and Hedgehog signaling pathway.
    Oral Oncol. 2022;134:106119.
    PubMed    


  32. VILLEGAS KM, Paparella ML
    Malignant odontogenic tumors. A report of a series of 30 cases and review of the literature.
    Oral Oncol. 2022;134:106068.
    PubMed     Abstract available


  33. YUWANATI M, Sarode SC, Sarode GS, Gadbail A, et al
    Telomerase reverse transcriptase mutation: A risk predictor and drug target for oral squamous cell carcinoma and its precursors.
    Oral Oncol. 2022;134:106120.
    PubMed    


  34. CHANDRALEKHA SELVAKUMAR S, Auxzilia Preethi K, Sekar D
    MicroRNAs and cancer-associated fibroblasts in the tumour microenvironment of oral squamous cell carcinoma (OSCC).
    Oral Oncol. 2022;134:106124.
    PubMed    


  35. YASASVE M, Saravanan M
    Role of dysregulated miRNAs profiles as hallmarks in the pathogenesis and differential regulation of tongue squamous cell carcinoma.
    Oral Oncol. 2022;134:106104.
    PubMed    


  36. ROH JL
    Superficial versus total parotidectomy for recurrent pleomorphic adenoma in the parotid gland.
    Oral Oncol. 2022;134:106103.
    PubMed     Abstract available


  37. SEKAR D, Selvakumar SC, Auxzilia Preethi K
    Therapeutic nature of microRNAs in Oral Squamous Cell Carcinoma (OSCC).
    Oral Oncol. 2022;134:106106.
    PubMed    


  38. ELUMALAI P, Ezhilarasan D
    Emerging applications of CRISPR/Cas9 gene editing technology in reversing drug resistance in oral squamous cell carcinoma.
    Oral Oncol. 2022;134:106100.
    PubMed    


  39. MANJUSHA M, Saravanan M
    Oropharyngeal cancer associated with sarcopenic obesity and sarcopenic weight loss.
    Oral Oncol. 2022;134:106101.
    PubMed    


  40. FITZGERALD CWR, Davies JC, de Almeida JR, Rich JT, et al
    Factors predicting pharyngocutaneous fistula in patients after salvage laryngectomy for laryngeal malignancy - A multicenter collaborative cohort study.
    Oral Oncol. 2022;134:106089.
    PubMed     Abstract available


  41. DE LUCA P, Scarpa A, Viola P, Motta G, et al
    Collision tumors of the larynx: A retrospective single-center case series of an extremely rare phenomenon.
    Oral Oncol. 2022;134:106096.
    PubMed    


  42. TOPKAN E, Somay E, Yilmaz B, Kucuk A, et al
    Comment on: Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study.
    Oral Oncol. 2022;134:106098.
    PubMed    


  43. KAJO K, Othman BK, Kajova Machalekova K
    Sclerosing Warthin-like mucoepidermoid carcinoma of the salivary gland.
    Oral Oncol. 2022;134:106090.
    PubMed    


  44. SEKARAN S, Ganapathy D
    Salivary microRNA- 375: A novel biomarker in the malignant transformation of oral potentially malignant disorders.
    Oral Oncol. 2022;134:106065.
    PubMed    


  45. FESTA BM, Costantino A, Ferreli F, Spriano G, et al
    The impact of frailty on adjuvant treatment in patients with head and neck free flap reconstruction-A retrospective study using two independent frailty scores: Avoiding the wrong conclusion.
    Oral Oncol. 2022;134:106071.
    PubMed    


  46. WEINBERGER JM, Abd El Qadir N, Hirshoren N
    Double trouble: A cohort study of re-irradiation and laryngectomy - Severity of and risk for pharyngocutaneous fistula.
    Oral Oncol. 2022;134:106069.
    PubMed     Abstract available


  47. DE BREE R, Leemans CR
    When to perform a paratracheal lymph node dissection during total laryngectomy?
    Oral Oncol. 2022;134:106048.
    PubMed    


  48. WU B, Shen L, Peng G, Li Y, et al
    Molecular characteristics of pediatric nasopharyngeal carcinoma using whole-exome sequencing.
    Oral Oncol. 2022;135:106218.
    PubMed     Abstract available


  49. HUANG J, Harris E, Lorch J
    Vaccination as a therapeutic strategy for Nasopharyngeal carcinoma.
    Oral Oncol. 2022;135:106083.
    PubMed     Abstract available


    October 2022
  50. XUE S, Song G, Zhu Y, Zhang N, et al
    The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A meta-analysis.
    Oral Oncol. 2022;135:106231.
    PubMed     Abstract available


  51. KAO DD, Ferrandino RM, Bauml JM, Marshall DC, et al
    Prophylactic feeding tube placement for squamous cell carcinoma of the head and neck.
    Oral Oncol. 2022;135:106216.
    PubMed     Abstract available


  52. ZHU L, Li M, Tang G, Shi L, et al
    Role of salivary miRNAs as noninvasive biomarkers in head and neck squamous cell carcinomas and oral potentially malignant disorders - Reply.
    Oral Oncol. 2022;135:106224.
    PubMed    


  53. DENNIS MJ, Sacco AG, Qi Y, Bykowski J, et al
    A phase I study of avelumab, palbociclib, and cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma.
    Oral Oncol. 2022;135:106219.
    PubMed     Abstract available


  54. GOVINDARASU M, Prathap L, Govindasamy R
    Histone deacetylase inhibitors regulate the oral cancer via PI3K/AKT signaling pathway.
    Oral Oncol. 2022;135:106221.
    PubMed    


  55. CHABRILLAC E, Lebars S, Breuskin I, Thariat J, et al
    Pregnancy-associated head and neck cancer:a partnership between theCORASSO patient association and theREFCOR physician networkto study a pathology of extremely rare occurrence.
    Oral Oncol. 2022;135:106223.
    PubMed    


  56. OLAWUNI FO, Sauer AB, Daher GS, Douse DM, et al
    The reporting and representation of sex and gender in head and neck cancer clinical trials.
    Oral Oncol. 2022;135:106217.
    PubMed    


  57. SUNDRAMOORTHY AK, Atchudan R, Arya S
    Utilization of Raman spectroscopy in biochemical fingerprint analysis for oral cancer screening and diagnosis.
    Oral Oncol. 2022;135:106192.
    PubMed    


  58. ZHU L, Deng Y, Ji T, Zhou H, et al
    Metformin and oral cancer: In reply with emphasis on an emerging role of an old drug in oral cancer chemoprevention.
    Oral Oncol. 2022;135:106196.
    PubMed    


  59. MANJUSHA M, Saravanan M
    Development of novel electrochemical based nano-biosensors for the diagnosis of oral potentially malignant disorders and oral carcinoma.
    Oral Oncol. 2022;135:106197.
    PubMed    


  60. SEKAR AA, Veeraraghavan VP, Raj AT, Patil S, et al
    Unravelling the long non-coding RNA, CYTOR can serve as a potential therapeutic target in oral cancer.
    Oral Oncol. 2022;135:106195.
    PubMed    


  61. GURMEET SINGH A, Sathe P, Roy S, Thiagrajan S, et al
    Incidence and impact of skip metastasis in the neck in early oral cancer: Reality or a myth?
    Oral Oncol. 2022;135:106201.
    PubMed     Abstract available


  62. KRISHNAMOORTHY K, Priya Veeraraghavan V, Jayaraman S
    E3 ubiquitin ligases: A therapeutic drug target in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;135:106193.
    PubMed    


  63. ZHU S, Zhang F, Zhao G, Zhang X, et al
    Trends in the global burden of oral cancer joint with attributable risk factors: Results from the global burden of disease study 2019.
    Oral Oncol. 2022;134:106189.
    PubMed     Abstract available


  64. LIU W, Ji T, Zhang C, Zhou Q, et al
    Cell-free DNA hypermethylated genes may have a limited role in cancer screening but a potential role in risk assessment of head and neck cancer.
    Oral Oncol. 2022;134:106129.
    PubMed     Abstract available


  65. YU C, Zhou Z
    Application of ultrasound-guided resections in surgical removal of squamous cell carcinoma of the tongue.
    Oral Oncol. 2022;133:106057.
    PubMed    


  66. FEENEY L, Hapuarachi B, Adderley H, Rack S, et al
    Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation.
    Oral Oncol. 2022;133:106028.
    PubMed     Abstract available


  67. MORING MM, Mast H, Wolvius EB, Verduijn GM, et al
    Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study.
    Oral Oncol. 2022;133:106056.
    PubMed     Abstract available


  68. AUXZILIA PREETHI K, Chandralekha Selvakumar S, Sekar D
    MicroRNAs and it's targets in the treatment of salivary adenoid cystic carcinoma.
    Oral Oncol. 2022;133:106053.
    PubMed    


  69. KEY S, Chia C, Hasan Z, Sundaresan P, et al
    Systematic review of prognostic factors in carcinoma ex pleomorphic adenoma.
    Oral Oncol. 2022;133:106052.
    PubMed     Abstract available


  70. ANGEL GONZALEZ-MOLES M, Ramos-Garcia P
    Overestimated risk of transformation in oral lichen planus: In reply.
    Oral Oncol. 2022;133:106045.
    PubMed    


  71. DE KONING KJ, van Es RJJ, Klijn RJ, Breimer GE, et al
    Application and accuracy of ultrasound-guided resections of tongue cancer.
    Oral Oncol. 2022;133:106023.
    PubMed     Abstract available


  72. NGUYEN ML, Hsieh ML, Henson C, Krempl G, et al
    Neoadjuvant QUAD shot for downstaging or temporizing locally advanced oral cavity cancer prior to definitive surgery.
    Oral Oncol. 2022;133:106029.
    PubMed     Abstract available


  73. SARAVANAN M, Kolade Omole R, Torimiro N
    Oncogenic virus in oral squamous cell carcinoma and the role of oncolytic HSV-1 viro-immunotherapy as an emerging treatment.
    Oral Oncol. 2022;133:106021.
    PubMed    


  74. CAI X, Zhang J, Zhang H, Li T, et al
    Overestimated risk of transformation in oral lichen planus.
    Oral Oncol. 2022;133:106025.
    PubMed     Abstract available


  75. SIVAPERUMAL P, Kamala K
    Bacteriophages as novel tumor targeting therapy for oral squamous cell carcinoma (OSCC) cancer.
    Oral Oncol. 2022;133:106020.
    PubMed    


  76. HENG Y, Yang Z, Lin J, Liu Q, et al
    Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis.
    Oral Oncol. 2022;134:106185.
    PubMed     Abstract available


    September 2022
  77. MORSE RT, Beaty B, Scanga L, Blumberg J, et al
    Diagnostic accuracy of FNA to determine HPV status in HPV-associated oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2022;134:106131.
    PubMed     Abstract available


  78. ZHU GL, Fang XL, Yang KB, Tang LL, et al
    Development and validation of a joint model for dynamic prediction of overall survival in nasopharyngeal carcinoma based on longitudinal post-treatment plasma cell-free Epstein-Barr virus DNA load.
    Oral Oncol. 2022;134:106140.
    PubMed     Abstract available


  79. XUE F, Ou D, Ou X, Zhou X, et al
    Long-term results of the phase II dose and volume de-escalation trial for locoregionally advanced nasopharyngeal carcinoma.
    Oral Oncol. 2022;134:106139.
    PubMed     Abstract available


  80. SANKAR S
    New insights into CAR T-cell therapy for recurrent head and neck squamous cell carcinoma.
    Oral Oncol. 2022;134:106137.
    PubMed    


  81. KMIECIK M, Nogal P, Wierzbicka M, Jackowska J, et al
    Anterolateral thigh free flap reconstruction of pharyngoesophageal defect caused by radiotherapy for laryngeal cancer: A case report.
    Oral Oncol. 2022;134:106135.
    PubMed     Abstract available


  82. GUPTA T, Kannan S, Ghosh-Laskar S, Agarwal JP, et al
    Concurrent chemoradiotherapy with cisplatin given once-a-week versus every-three weekly in head and neck squamous cell carcinoma: Non-inferior, equivalent, or superior?
    Oral Oncol. 2022;134:106130.
    PubMed     Abstract available


  83. HITT R, Mesia R, Lozano A, Iglesias Docampo L, et al
    Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer.
    Oral Oncol. 2022;134:106087.
    PubMed     Abstract available


  84. ZHANG J, Wu HY, Lu Q, Shan XF, et al
    Effects of personalized swallowing rehabilitation in patients with oral cancer after free flap transplantation: A cluster randomized controlled trial.
    Oral Oncol. 2022;134:106097.
    PubMed     Abstract available


  85. PATIL V, Kumar S, Noronha V, Menon N, et al
    Long term outcomes of a randomized controlled clinical trial comparing the efficacy of Cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancer.
    Oral Oncol. 2022;134:106085.
    PubMed    


  86. SARODE GS, Anand R, Sharma NK, Sarode SC, et al
    Hot and cold tumor: Recent developments and perspectives on oral cancer.
    Oral Oncol. 2022;134:106114.
    PubMed    


  87. BEOM HEO D, Piao Y, Hee Lee J, Ju SH, et al
    Completion thyroidectomy may not be required for papillary thyroid carcinoma with multifocality, lymphovascular invasion, extrathyroidal extension to the strap muscles, or five or more central lymph node micrometastasis.
    Oral Oncol. 2022;134:106115.
    PubMed     Abstract available


  88. SAHNI V, Kumar A, Gupta S, Sharma S, et al
    Metformin and oral cancer.
    Oral Oncol. 2022;134:106125.
    PubMed    


  89. TOBIAS MAS, Nogueira BP, Santana MCS, Pires RG, et al
    Artificial intelligence for oral cancer diagnosis: What are the possibilities?
    Oral Oncol. 2022;134:106117.
    PubMed     Abstract available


  90. SHREE HARINI K, Ezhilarasan D, Elumalai P
    Restoring the anti-tumor property of PTEN: A promising oral cancer treatment.
    Oral Oncol. 2022;134:106113.
    PubMed    


  91. NONG T, Medrano T, Marrero C, Rubens M, et al
    Radiation induced taste changes in head and neck cancer - differential impact of treatment factors.
    Oral Oncol. 2022;134:106105.
    PubMed    


  92. MUTHUKRISHNAN L
    "TGM3 - A novel biomarker as a potential diagnostic target for head and neck squamous cell carcinoma (HNSCC)".
    Oral Oncol. 2022;134:106118.
    PubMed    


  93. MONY U, Priya Veeraraghavan V
    "Rules" to the genetic progression of tumours deciphered: Is it time to think differently in treating oral cancer patients?
    Oral Oncol. 2022;134:106111.
    PubMed    


  94. PRASAD M, Jayaraman S, Rajagopal P, Veeraraghavan VP, et al
    Apoptosis regulating CircRNAs: Emerging role in oral cancer therapeutics.
    Oral Oncol. 2022;134:106107.
    PubMed    


  95. DE WIT JG, van Schaik JE, Voskuil FJ, Vonk J, et al
    Comparison of narrow band and fluorescence molecular imaging to improve intraoperative tumour margin assessment in oral cancer surgery.
    Oral Oncol. 2022;134:106099.
    PubMed     Abstract available


  96. VILASECA I, Xavier Aviles-Jurado F, Lehrer E, Valduvieco I, et al
    CO2-TOLMS for laryngeal cancer in the elderly, pushing the boundaries of partial laryngectomy.
    Oral Oncol. 2022;134:106088.
    PubMed     Abstract available


  97. YUAN H, Yan M, Liang X, Liu W, et al
    Decoding the associations between cell functional states in head and neck cancer based on single-cell transcriptome.
    Oral Oncol. 2022;134:106110.
    PubMed     Abstract available


  98. BALACHANDER K, Vijayashree Priyadharsini J, Paramasivam A
    Advances in oral cancer early diagnosis and treatment strategies with liquid biopsy-based approaches.
    Oral Oncol. 2022;134:106108.
    PubMed    


  99. TAKENAKA Y, Takemoto N, Otsuka T, Nishio M, et al
    Predictive significance of body composition indices in patients with head and neck squamous cell carcinoma treated with nivolumab: A multicenter retrospective study.
    Oral Oncol. 2022;132:106018.
    PubMed     Abstract available


  100. LIU AQ, Deane EC, Heffernan A, Ji Y, et al
    Patient-reported outcomes and morbidity after head and neck reconstructions: An evaluation of fibular and scapular free flaps.
    Oral Oncol. 2022;132:106019.
    PubMed     Abstract available


  101. SHAH HP, Cohen O, Sukys J, Dibble J, et al
    The impact of frailty on adjuvant treatment in patients with head and neck free flap reconstruction-A retrospective study using two independent frailty scores.
    Oral Oncol. 2022;132:106006.
    PubMed     Abstract available


  102. AMITH K P, V Lal R, Lakshmi Pandey R, Thakur S, et al
    Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma - "Need for incorporation of sub classification of pT4b lesions".
    Oral Oncol. 2022;132:106014.
    PubMed    


  103. CHABRILLAC E, Jackson R, Mattei P, D'Andrea G, et al
    Paratracheal lymph node dissection during total (pharyngo-)laryngectomy: A systematic review and meta-analysis.
    Oral Oncol. 2022;132:106017.
    PubMed     Abstract available


  104. DAS R, Satya Sai Reddy Gontu G, Das K, Das A, et al
    Validation of ATA guidelines for Indian population: Do ATA guidelines have an impact on management of DTC patients in Indian population - A 5 year retrospective cohort analysis.
    Oral Oncol. 2022;132:106016.
    PubMed    


  105. SOARES CD, Santana T, Lacerda de Souza L, Paes de Almeida O, et al
    Intraductal carcinoma of the submandibular gland: A case report.
    Oral Oncol. 2022;132:106010.
    PubMed    


  106. K P A, Thakur S, Hanagvadi S, Siva Bharani KSN, et al
    "Haemophilia A" - Presenting with oral squamous cell carcinoma diagnosis and management strategies.
    Oral Oncol. 2022;132:105994.
    PubMed     Abstract available


  107. TASSONE P, Caruso C, White M, Tavares Dos Santos H, et al
    The role of matrixmetalloproteinase-2 expression by fibroblasts in perineural invasion by oral cavity squamous cell carcinoma.
    Oral Oncol. 2022;132:106002.
    PubMed     Abstract available


  108. MARINHO MFP, Marinho MCFL, de Andrade BAB, Pinto MAVR, et al
    Oral squamous cell carcinoma clinically resembling BRONJ.
    Oral Oncol. 2022;132:105974.
    PubMed    


  109. YANG X, Yang X, Ji T, Zhou Q, et al
    A bibliometric analysis of the papers on oral potentially malignant disorder in Oral Oncology.
    Oral Oncol. 2022;132:105996.
    PubMed    


  110. FERRER-SANCHEZ A, Bagan J, Vila-Frances J, Magdalena-Benedito R, et al
    Prediction of the risk of cancer and the grade of dysplasia in leukoplakia lesions using deep learning.
    Oral Oncol. 2022;132:105967.
    PubMed     Abstract available


  111. CALABRESE L, Nocini R, Spirito F, Gazzini L, et al
    Response to the comment on "The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations".
    Oral Oncol. 2022;132:105984.
    PubMed    


  112. CABRAL RAMOS J, Cesar Silva L, Schausltz Pereira Faustino I, Carolina Evangelista Colafemina A, et al
    A rare case of squamous cell carcinoma of the gingiva: A diagnostic challenge.
    Oral Oncol. 2022;132:105995.
    PubMed     Abstract available


  113. DENG W, Zhao G, Li Z, Yang L, et al
    Recovery pattern analysis of swallowing function in patients undergoing total glossectomy and hemiglossectomy.
    Oral Oncol. 2022;132:105981.
    PubMed     Abstract available


  114. JACOBS CD, Barak I, Jung SH, Rocke DJ, et al
    Prediction model to estimate overall survival benefit of postoperative radiotherapy for resected major salivary gland cancers.
    Oral Oncol. 2022;132:105955.
    PubMed     Abstract available


  115. SIEVERT M, Oetter N, Mantsopoulos K, Gostian AO, et al
    Systematic classification of confocal laser endomicroscopy for the diagnosis of oral cavity carcinoma.
    Oral Oncol. 2022;132:105978.
    PubMed     Abstract available


    August 2022
  116. CHANDRALEKHA SELVAKUMAR S, Auxzilia Preethi K, Sekar D
    Non-coding RNAs influencing anti PD-1 immunotherapy in head and neck squamous cell carcinoma (HNSCC).
    Oral Oncol. 2022;134:106092.
    PubMed    


  117. YADALAM PK, Anegundi RV, Ramadoss R, Joseph B, et al
    Felodipine repurposed for targeting TRPV1 receptor to relieve oral cancer pain.
    Oral Oncol. 2022;134:106094.
    PubMed    


  118. SEMPRINI J
    Oral cancer screening prevalence in low-income adults before and after the ACA.
    Oral Oncol. 2022;134:106055.
    PubMed     Abstract available


  119. PAZHANI J, Veeraraghavan VP, Jayaraman S
    Aurora kinase in oral cancer: A potential therapeutic target to improve treatment efficiency.
    Oral Oncol. 2022;134:106093.
    PubMed    


  120. KRUTZ M, Acharya P, Chissoe G, Raj V, et al
    Tobacco cessation after head and neck cancer diagnosis is an independent predictor of treatment response and long-term survival.
    Oral Oncol. 2022;134:106072.
    PubMed     Abstract available


  121. HEMPENIUS MA, Bisheshar SK, Slagter-Menkema L, van der Kamp MF, et al
    Inter-assay reliability of programmed cell death-ligand 1 in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;134:106086.
    PubMed     Abstract available


  122. VAISH R, Mittal N, Mahajan A, Rane SU, et al
    Sentinel node biopsy in node negative early oral cancers: Solution to the conundrum!
    Oral Oncol. 2022;134:106070.
    PubMed     Abstract available


  123. MUTHUPANDIAN S, Muralidharan M, Madhavan Y, Hariharan NM, et al
    Prospective role of salivary MicroRNA for early detection - personalized therapy of head and neck squamous cell carcinoma.
    Oral Oncol. 2022;134:106063.
    PubMed    


  124. PARAMASIVAM A
    Circulating circular RNAs: Novel potential biomarkers and therapeutic targets for oral cancer.
    Oral Oncol. 2022;134:106067.
    PubMed    


  125. EZHILARASAN D, Shree Harini K
    Novel mTOR inhibitors: Promising therapeutic interventions in oral cancer therapy.
    Oral Oncol. 2022;133:106066.
    PubMed    


  126. PRASAD M, Veeraraghavan VP, Jayaraman S
    Tumorigenic potential of GLUT4: A therapeutic target for head and neck squamous cell carcinoma.
    Oral Oncol. 2022;133:106061.
    PubMed    


  127. YU C, Zhou Z
    Relationship between young non-smokers and oral cancer: What can we learn?
    Oral Oncol. 2022;133:106064.
    PubMed    


  128. REKHA K, Venkidasamy B, Govindasamy R, Neralla M, et al
    Isothiocyanates (AITC & BITC) bioactive molecules: Therapeutic potential for oral cancer.
    Oral Oncol. 2022;133:106060.
    PubMed    


  129. BALACHANDER K, Abilasha R, Priyadharsini JV, Balamurugan R, et al
    Targeting mitochondria for apoptosis in oral cancer: Therapeutic potential and obstacles.
    Oral Oncol. 2022;133:106059.
    PubMed    


  130. SARODE GS, Kumari N, Gophane R, Ghone U, et al
    Trends and prospects in oral cancer vaccine.
    Oral Oncol. 2022;133:106051.
    PubMed    


  131. MA SJ, Yu H, Khan M, Yu B, et al
    Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients receiving chemoradiation.
    Oral Oncol. 2022;133:106054.
    PubMed     Abstract available


  132. VERDONCK-DE LEEUW I, Dawson C, Licitra L, Eriksen JG, et al
    European Head and Neck Society recommendations for head and neck cancer survivorship care.
    Oral Oncol. 2022;133:106047.
    PubMed     Abstract available


  133. LU HJ, Peng CY, Tseng HC, Hsin CH, et al
    Preoperative prediction model to evaluate salvage surgery in patients with recurrent or second primary oral cavity squamous cell carcinoma.
    Oral Oncol. 2022;131:105951.
    PubMed     Abstract available


  134. ZANOLETTI E, Tealdo G, Franz L, Cazzador D, et al
    From "Extended total parotidectomy" to "Temporo-parotid resection" for locally advanced parotid tumors: Outlining a shift in surgical perspective.
    Oral Oncol. 2022;131:105975.
    PubMed    


  135. STANBOULY D, Philipone E, Morlandt AB, Kaleem A, et al
    Adverse events secondary to cetuximab therapy in head & neck cancer therapy and risk factors for serious outcomes.
    Oral Oncol. 2022;131:105952.
    PubMed     Abstract available


  136. SIVAPERUMAL P, Sekaran S, Kamala K, Ganapathy D, et al
    Marine bioactive compounds as potential therapeutic inhibitor for oral squamous cell carcinoma (OSCC).
    Oral Oncol. 2022;131:105971.
    PubMed    


  137. WU Y, Koyuncu CF, Toro P, Corredor G, et al
    A machine learning model for separating epithelial and stromal regions in oral cavity squamous cell carcinomas using H&E-stained histology images: A multi-center, retrospective study.
    Oral Oncol. 2022;131:105942.
    PubMed     Abstract available


  138. HAN N, Li X, Wang Y, Li H, et al
    HIF-1alpha induced NID1 expression promotes pulmonary metastases via the PI3K-AKT pathway in salivary gland adenoid cystic carcinoma.
    Oral Oncol. 2022;131:105940.
    PubMed     Abstract available


  139. DONA MG, Rollo F, Pichi B, Moretto S, et al
    Updates on Human Papillomavirus-driven oropharyngeal squamous cell carcinomas in a southern European country.
    Oral Oncol. 2022;131:105947.
    PubMed    


    July 2022
  140. DASSE R, Dupin C, Gorphe P, Temam S, et al
    Proposal for an algorithm to avoid neck dissection during salvage total laryngectomy. A GETTEC multicentric study.
    Oral Oncol. 2022;133:106026.
    PubMed     Abstract available


  141. CHOW JCH, Lee AWM, Wong CHL, Ng WT, et al
    Epstein-Barr virus directed screening for nasopharyngeal carcinoma in individuals with positive family history: A systematic review.
    Oral Oncol. 2022;133:106031.
    PubMed     Abstract available


  142. KRISHNAN M, Venkidasamy B
    PEITC: A prospective natural metabolite in oral cancer treatment.
    Oral Oncol. 2022;133:106044.
    PubMed    


  143. YU C, Zhou Z
    Assessment of oral dysfunction after oral cancer treatment.
    Oral Oncol. 2022;133:106046.
    PubMed    


  144. SARODE GS, Sarode SC, Kumari N, Gophane R, et al
    FAP-targeted imaging in oral cancer: Critical viewpoints.
    Oral Oncol. 2022;133:106024.
    PubMed    


  145. YASASVE M, Manjusha M, Saravanan M
    Polymorphism in pro-inflammatory cytokines and their genetic susceptibility towards oral precancerous lesions and oral cancer.
    Oral Oncol. 2022;133:106027.
    PubMed    


  146. KONO M, Saito S, Egloff AM, Allen CT, et al
    The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations.
    Oral Oncol. 2022;132:106012.
    PubMed     Abstract available


  147. MELO G, Silva CAB, Hague A, Parkinson EK, et al
    Anticancer effects of putative and validated BH3-mimetic drugs in head and neck squamous cell carcinomas: An overview of current knowledge.
    Oral Oncol. 2022;132:105979.
    PubMed     Abstract available


  148. KUMARESAN V, Sivaperumal P, Smiline Girija AS
    Bispecific antibodies targeting tumor-associated metalloprotease and recruit NK cells - Multifunctional therapeutic approach against oral cancer.
    Oral Oncol. 2022;132:106013.
    PubMed    


  149. RENU K, Veeraraghavan VP, Raj A T, Patil S, et al
    The peroxisome proliferator-activated receptor-alpha (PPAR-alpha): A new therapeutic target for oral cancer.
    Oral Oncol. 2022;132:106007.
    PubMed    


  150. ALLEN JL, Hames RA, Mastroianni NM, Greenstein AE, et al
    Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma.
    Oral Oncol. 2022;132:106008.
    PubMed     Abstract available


  151. SARODE GS, Kumari N, Sarode SC
    Oral cancer histopathology images and artificial intelligence: A pathologist's perspective.
    Oral Oncol. 2022;132:105999.
    PubMed    


  152. DE VRIES J, Poelman A, Sidorenkov G, Festen S, et al
    The association of frailty and outcomes of geriatric assessment with acute radiation-induced toxicity in patients with head and neck cancer.
    Oral Oncol. 2022;130:105933.
    PubMed     Abstract available


  153. RIBEIRO MFA, Oliveira MCM, Leite AC, Bruzinga FFB, et al
    Assessment of screening programs as a strategy for early detection of oral cancer: a systematic review.
    Oral Oncol. 2022;130:105936.
    PubMed     Abstract available


  154. KAZEMIAN E, Solinski M, Adams W, Moore M, et al
    The role of perineural invasion in parotid malignancy outcomes: A systematic review and meta-analysis.
    Oral Oncol. 2022;130:105937.
    PubMed     Abstract available


  155. JAYARAMAN S, Sekar R, Veeraraghavan VP, Raj AT, et al
    MALAT 1 a modulator of PD-1/PD-L1 regulation in oral malignancies: An emerging target in cancer therapy.
    Oral Oncol. 2022;130:105950.
    PubMed    


  156. FANG Y, Peng Z, Wang Y, Gao K, et al
    Current opinions on diagnosis and treatment of adenoid cystic carcinoma.
    Oral Oncol. 2022;130:105945.
    PubMed     Abstract available


  157. MIN Y, Feng Y, He D, Zeng X, et al
    Is Age >/= 55 years an optimal cutoff point among patients with differentiated thyroid Microcarcinoma? a preliminary study.
    Oral Oncol. 2022;130:105938.
    PubMed     Abstract available


  158. LI C, Zhang Q, Sun K, Jia H, et al
    Autofluorescence imaging as a noninvasive tool of risk stratification for malignant transformation of oral leukoplakia: A follow-up cohort study.
    Oral Oncol. 2022;130:105941.
    PubMed     Abstract available


  159. PONNIAH I
    "In response to "Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia".
    Oral Oncol. 2022;130:105944.
    PubMed    


  160. MENDONCA P, Sunny SP, Mohan U, Birur N P, et al
    Non-invasive imaging of oral potentially malignant and malignant lesions: A systematic review and meta-analysis.
    Oral Oncol. 2022;130:105877.
    PubMed     Abstract available


  161. KIL WJ
    Rapid physical and emotional palliation from QUAD shot radiotherapy to a frail elderly patient with stage IV parotid gland cancer-associated facial paralysis and pain when no other palliative intervention was available during COVID-19 pandemic.
    Oral Oncol. 2022;130:105930.
    PubMed    


  162. SELVAKUMAR SC, K Auxzilia P, Dinesh Y, Senthilmurugan M, et al
    MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma.
    Oral Oncol. 2022;130:105925.
    PubMed    


  163. KIONG KL, Moreno A, Vu CN, Zheng G, et al
    Enhanced recovery after surgery (ERAS) in head and neck oncologic surgery: Impact on return to intended oncologic therapy (RIOT) and survival.
    Oral Oncol. 2022;130:105906.
    PubMed     Abstract available


  164. MA P, Shen HY, Chen DS, Lu ZY, et al
    Anti-PD-1 plus anti-HER2 and chemotherapy showed superior and durable clinical benefit in a patient with advanced salivary duct carcinoma.
    Oral Oncol. 2022;130:105905.
    PubMed    


  165. TANG R, Mao S, Liu S, Li Z, et al
    Types of endoscopic surgical approaches for benign parapharyngeal space tumors.
    Oral Oncol. 2022;130:105875.
    PubMed    


  166. DOLL C, Mrosk F, Wuester J, Runge AS, et al
    Pattern of cervical lymph node metastases in squamous cell carcinoma of the upper oral cavity - How to manage the neck.
    Oral Oncol. 2022;130:105898.
    PubMed     Abstract available


  167. MAZEROLLE P, Fuchsmann C, Schultz P, Benmoussa N, et al
    Salvage total glossectomy and total glosso-laryngectomy: Are they worth it? A GETTEC French multicenter study.
    Oral Oncol. 2022;130:105896.
    PubMed     Abstract available


  168. VIGARIOS E, Warnakulasuriya S, Piau A, Giraudeau N, et al
    Early detection of oral malignancies may involve the development of tele-expertise in dentistry.
    Oral Oncol. 2022;130:105904.
    PubMed    


  169. YANG X, Zhou T, Ji T, Jia H, et al
    Comment on circulatory miRNAs as therapeutic molecules for oral potentially malignant disorder and oral squamous cell carcinoma.
    Oral Oncol. 2022;130:105901.
    PubMed    


  170. JAYASEELAN VP, A S SG, Arumugam P
    Engineered therapeutic bacteria for the treatment of oral squamous cell carcinoma.
    Oral Oncol. 2022;130:105874.
    PubMed    


  171. EZHILARASAN D, Shree Harini K, Lakshmi T
    Osteopontin: A reliable diagnostic marker and an attractive therapeutic target in oral cancers.
    Oral Oncol. 2022;132:106005.
    PubMed    


    June 2022
  172. MISRA SR, Das R
    Central oral medicine repository: A proposal to speed up the diagnostic process for oral potentially malignant disorders and oral carcinoma!
    Oral Oncol. 2022;132:105998.
    PubMed    


  173. BALACHANDER K, Paramasivam A
    Anti-PD-1 agent: A promising immunotherapy drug for oral cancer?
    Oral Oncol. 2022;132:105997.
    PubMed    


  174. BABU S, Krishnan M, Priya Veeraraghavan V, Jayaraman S, et al
    Role of salivary miRNAs in the diagnosis and prognosis of head and neck squamous cell carcinoma.
    Oral Oncol. 2022;132:105993.
    PubMed    


  175. ALESSANDRINI L, Ferrari M, Taboni S, Sbaraglia M, et al
    Tumor-stroma ratio, neoangiogenesis and prognosis in laryngeal carcinoma. A pilot study on preoperative biopsies and matched surgical specimens.
    Oral Oncol. 2022;132:105982.
    PubMed     Abstract available


  176. SHREE HARINI K, Ezhilarasan D, Lakshmi T
    Novel fibroblast growth factor receptor inhibitors: Potential therapeutic approach in oral cancer treatment.
    Oral Oncol. 2022;132:105983.
    PubMed    


  177. REVATHI D, Dhanraj G, Ashok V
    Immune check point inhibitors: A promising therapeutic approach in oral cancer.
    Oral Oncol. 2022;132:105977.
    PubMed    


  178. SEKARAN S, Pitchaiah S, Ganapathy D
    Can miR-21 be considered as a potential biomarker and a therapeutic target in oral cancer?
    Oral Oncol. 2022;131:105973.
    PubMed    


  179. ZONG J, Ji P, Lin C, Zhang R, et al
    Plasma Epstein-Barr viral DNA load after completion of two cycles of induction chemotherapy predicts outcomes for patients with advanced-stage nasopharyngeal carcinoma.
    Oral Oncol. 2022;131:105972.
    PubMed     Abstract available


  180. BALACHANDER K, Paramasivam A
    Ferroptosis: An emerging therapeutic target for oral cancer.
    Oral Oncol. 2022;131:105970.
    PubMed    


  181. GANAPATHY D, Sekaran S, Pitchaiah S
    Is prognostic monitoring of high-risk populations at risk for oral cancer necessary after infection with COVID-19?
    Oral Oncol. 2022;131:105968.
    PubMed    


  182. LUO HD, Xia FJ, Wu JH, Yi B, et al
    Efficacy of chemoradiotherapy in survival of stage nasopharyngeal carcinoma and establishment of a prognostic model.
    Oral Oncol. 2022;131:105927.
    PubMed     Abstract available


  183. SHREE HARINI K, Ezhilarasan D, Lakshmi T
    Patient derived tumour organoids: An emerging strategy in oral cancer research and therapeutics.
    Oral Oncol. 2022;131:105954.
    PubMed    


  184. VARGHESE BT, Nair SP, Janardhan D
    Transglottic intralaryngeal papillary thyroid carcinoma.
    Oral Oncol. 2022;131:105935.
    PubMed     Abstract available


  185. YANG Z, Liao J, Schumaker L, Carter-Cooper B, et al
    Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma.
    Oral Oncol. 2022;131:105939.
    PubMed     Abstract available


  186. SHREE HARINI K, Ezhilarasan D
    Promising autophagy inhibitors: Therapeutic implications in oral cancer.
    Oral Oncol. 2022;131:105948.
    PubMed    


  187. DE FELICE F
    FLASH radiotherapy in head and neck cancer: Myth or reality?
    Oral Oncol. 2022;131:105953.
    PubMed    


  188. VIJAYASHREE PRIYADHARSINI J, Anitha P
    Quantitative malignant index diagnosis system (qMIDS) for effective diagnosis of oral premalignant lesions.
    Oral Oncol. 2022;129:105902.
    PubMed    


  189. LEBOUCHER A, Sotton S, Gambin Flandrin I, Magne N, et al
    Head and neck radiotherapy-induced carotid toxicity: Pathophysiological concepts and clinical syndromes.
    Oral Oncol. 2022;129:105868.
    PubMed     Abstract available


  190. BALACHANDER K, Paramasivam A
    Mitophagy: A therapeutic target for oral squamous cell carcinoma.
    Oral Oncol. 2022;129:105881.
    PubMed    


  191. FERRELI F, Pirola F, Di Santo D, De Virgilio A, et al
    A critical analysis of the classifications of squamous cell carcinoma of the nasal vestibule.
    Oral Oncol. 2022;129:105880.
    PubMed    


  192. PAQUIN R, Gill B, Martin E, Byrd JK, et al
    Base of tongue neuroendocrine carcinoma: A case report.
    Oral Oncol. 2022;129:105780.
    PubMed     Abstract available


    May 2022
  193. JAYARAMAN S, Pazhani J, PriyaVeeraraghavan V, Raj AT, et al
    PCNA and Ki67: Prognostic proliferation markers for oral cancer.
    Oral Oncol. 2022;130:105943.
    PubMed    


  194. BALACHANDER K, Paramasivam A
    Selective autophagy as a potential therapeutic target for oral cancer.
    Oral Oncol. 2022;130:105934.
    PubMed    


  195. PATIL VM, Kolkur M, Kumar Chinthala S, Waratkar G, et al
    Long term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin-ineligible head and neck cancer patients.
    Oral Oncol. 2022;130:105908.
    PubMed    


  196. UEDA Y, Okano S, Enokida T, Fujisawa T, et al
    Nivolumab for recurrent or metastatic head and neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study.
    Oral Oncol. 2022;130:105932.
    PubMed     Abstract available


  197. WARNER L, O'Hara JT, Lin DJ, Oozeer N, et al
    Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomes.
    Oral Oncol. 2022;130:105909.
    PubMed     Abstract available


  198. VARGHESE BT, Shivanesan P
    Anatomical distortion of the right recurrent laryngeal nerve in level 7 neck dissection.
    Oral Oncol. 2022;130:105929.
    PubMed    


  199. SMILINE GIRIJA AS
    Natural "epidrugs" and the need of basket trials in the treatment of oral cancer in India.
    Oral Oncol. 2022;130:105931.
    PubMed    


  200. SHIAO JC, Holt D, Ladbury C, Gao D, et al
    The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2022;130:105907.
    PubMed     Abstract available


  201. LOW SK, Reed CT, Millo C, Turkbey EB, et al
    Cecal mass: An unusual site of metastasis from HPV-associated oropharyngeal cancer.
    Oral Oncol. 2022;130:105928.
    PubMed    


  202. PARAMASIVAM A
    Plasma circulating tumor DNA as a molecular marker for oral cancer.
    Oral Oncol. 2022;130:105926.
    PubMed    


  203. SELVARAJ J, Yasothkumar D, Vishnu Priya V, Raj AT, et al
    Development and tumorigenic potential of TP53: A therapeutic target for head and neck squamous cell carcinoma.
    Oral Oncol. 2022;130:105922.
    PubMed    


  204. YANG X, Song H, Ji T, Du G, et al
    The implications of gene mutations in salivary DNA for noninvasive diagnosis of head and neck cancer with a focus on oral cancer.
    Oral Oncol. 2022;130:105924.
    PubMed     Abstract available


  205. FORNER D, Mok F, Verma N, Karam I, et al
    Placement technique impacts gastrostomy tube-related complications amongst head and neck cancer patients.
    Oral Oncol. 2022;130:105903.
    PubMed     Abstract available


  206. PAZHANI J, Jayaraman S, Veeraraghavan VP, Somasundaram DB, et al
    Targeting cancer associated fibroblasts - A TGF-beta based immunotherapy for head and neck squamous cell carcinoma.
    Oral Oncol. 2022;130:105899.
    PubMed    


  207. JIANG Y, Yang S, Qi Y
    Comment on: The prognostic value of radiologic extranodal extension in nasopharyngeal carcinoma: Systematic review and meta-analysis.
    Oral Oncol. 2022;130:105872.
    PubMed    


  208. MADY LJ, Baddour K, Hodges JC, Magana LC, et al
    Corrigendum to "The impact of frailty on mortality in non-surgical head and neck cancer treatment: Shifting the clinical paradigm" [Oral Oncol. 126 (2022) 105766].
    Oral Oncol. 2022 May 2:105882. doi: 10.1016/j.oraloncology.2022.105882.
    PubMed    


  209. SWARTZ JE, Smits HJG, Philippens MEP, de Bree R, et al
    Correlation and colocalization of HIF-1alpha and pimonidazole staining for hypoxia in laryngeal squamous cell carcinomas: A digital, single-cell-based analysis.
    Oral Oncol. 2022;128:105862.
    PubMed     Abstract available


  210. YEOM S, Jung EK, Lee DH, Lee JK, et al
    Clinical features and recurrence factors of benign neoplasms of the tongue base.
    Oral Oncol. 2022;128:105866.
    PubMed     Abstract available


  211. COUTU B, Ryan E, Christensen D, Lawrence E, et al
    Positive margins matter regardless of subsequent resection findings.
    Oral Oncol. 2022;128:105850.
    PubMed     Abstract available


  212. MULLER RG, Hamill CS, Vu B, Thuener J, et al
    Impact of AJCC 8th edition staging system and definitive treatment choice on the prognosis of complete responders with p16+ and p16- oropharyngeal squamous cell carcinomas.
    Oral Oncol. 2022;128:105861.
    PubMed     Abstract available


  213. MOLNAR K, Hietanen S, Liisanantti J, Koivunen P, et al
    Quality of life after free flap reconstruction for the cancer of the head and neck: Comparison between five-year survivors and non-survivors.
    Oral Oncol. 2022;128:105855.
    PubMed     Abstract available


  214. TRANCHITO E, Cabrera C, Terry M, Li S, et al
    Occult nodal metastasis in major salivary gland malignancy: An update from the National Cancer Database.
    Oral Oncol. 2022;128:105829.
    PubMed     Abstract available


  215. WEN X, Hu Y, Liu Y, Li Z, et al
    Conservative treatment of head and neck lymphoma is not the only effective treatment: A retrospective analysis of 301 cases.
    Oral Oncol. 2022;128:105828.
    PubMed     Abstract available


    April 2022
  216. GALLOGLY JA JR, Weber AK, Mazul AL, Brinkmeier JV, et al
    Inferior outcomes associated with emergency department presentation for head and neck cancer surgery.
    Oral Oncol. 2022;129:105894.
    PubMed     Abstract available


  217. SHE L, Tian K, Han J, Zuo W, et al
    Pembrolizumab with or without chemotherapy versus cetuximab plus chemotherapy to treat recurrent or metastatic head and neck squamous cell carcinoma: An updated KEYNOTE-048 based cost-effectiveness analysis.
    Oral Oncol. 2022;129:105871.
    PubMed     Abstract available


  218. KATO A, Matsuda Y, Morioka R, Okui T, et al
    Discrepancy between subjective and objective postoperative oral dysfunction assessment after oral cancer treatment: A single-center cross-sectional study.
    Oral Oncol. 2022;129:105879.
    PubMed     Abstract available


  219. HAIST C, Poschinski Z, Bister A, Hoffmann MJ, et al
    Engineering a single-chain variable fragment of cetuximab for CAR T-cell therapy against head and neck squamous cell carcinomas.
    Oral Oncol. 2022;129:105867.
    PubMed     Abstract available


  220. SEKAR D, Panagal M, Manimaran D, Ahmad N, et al
    miR-185 and its anti-miR as a biomarker and therapeutic target for oral cancer.
    Oral Oncol. 2022;129:105873.
    PubMed    


  221. LIU T, Ma L, Song L, Yan B, et al
    CENPM upregulation by E5 oncoprotein of human papillomavirus promotes radiosensitivity in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;129:105858.
    PubMed     Abstract available


  222. NERALLA M, Senthilnthan P, Kubendiran D, Nandan A, et al
    Dry needle therapy for post operative shoulder dysfunction in oral cancer patients.
    Oral Oncol. 2022;128:105865.
    PubMed    


  223. PETRELLI F, Trevisan F, Ghidini A, Capriotti V, et al
    Comparison of platinum-based regimens in combination with radiotherapy for head and neck cancers: A network meta-analysis.
    Oral Oncol. 2022;128:105864.
    PubMed    


  224. ZHOU S, Chan C, Rulach R, Dyab H, et al
    Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.
    Oral Oncol. 2022;128:105870.
    PubMed     Abstract available


  225. YANG ZC, Nie ZQ, Chen QY, Du CC, et al
    Cost-Effectiveness analysis of combining plasma Epstein-Barr virus DNA testing and different surveillance imaging modalities for nasopharyngeal carcinoma patients in first remission.
    Oral Oncol. 2022;128:105851.
    PubMed     Abstract available


  226. FENG G, Feng H, Qi Y, Wang T, et al
    Interaction analysis between germline genetic variants and somatic mutations in head and neck cancer.
    Oral Oncol. 2022;128:105859.
    PubMed     Abstract available


  227. CHEN Y, Zheng X, Lin J, Gao X, et al
    A high homologous recombination deficiency score is associated with poor survival and a non-inflamed tumor microenvironment in head and neck squamous cell carcinoma patients.
    Oral Oncol. 2022;128:105860.
    PubMed     Abstract available


  228. TIAN K, Han J, Wang Z, Chen J, et al
    Immune checkpoint inhibition in first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A CAPTAIN-1st and JUPITER-02 trial-based cost-effectiveness analysis.
    Oral Oncol. 2022;128:105842.
    PubMed     Abstract available


  229. BALACHANDER K, Roy A, Priyadharsini JV, Murugan S, et al
    Mitochondrial DNA in circulating exosomes: A novel biomarker and potential therapeutic target for oral cancer.
    Oral Oncol. 2022;128:105857.
    PubMed    


  230. DE LA COUR CD, Munk C, Aalborg GL, Kjaer SK, et al
    Base of tongue/tonsillar and laryngeal cancer in Denmark 1994-2018: Temporal trends in incidence according to education and age.
    Oral Oncol. 2022;128:105832.
    PubMed     Abstract available


  231. BANERJEE A, Misra SR, Roy B, Singh S, et al
    Central oral histopathology registry (COHR) - A proposal promising hope for oral cancer and oral pathology research.
    Oral Oncol. 2022;128:105856.
    PubMed    


  232. SEKAR D, Murthykumar K, Ganapathy D
    miR-206 and its mimics: A predictive biomarker and therapeutic molecule in the treatment of oral cancer.
    Oral Oncol. 2022;128:105849.
    PubMed    


  233. RISCHIN D, Harrington KJ, Greil R, Soulieres D, et al
    Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
    Oral Oncol. 2022;128:105815.
    PubMed     Abstract available


  234. VAIDYA K, Sarode SC, Gadre P, Gadre K, et al
    Mammary analogue secretory carcinoma presenting as localized hematoma of the palate.
    Oral Oncol. 2022;127:105821.
    PubMed    


  235. BIJAI LK, Muthukrishnan A
    Potential role of fibroblast senescence in malignant transformation of oral submucous fibrosis.
    Oral Oncol. 2022;127:105810.
    PubMed     Abstract available


  236. NAMRATA D, Lakshmi T, Rushabh D, Ezhilarasan D, et al
    Role of stress management in oral malignant and premalignant conditions.
    Oral Oncol. 2022;127:105813.
    PubMed    


  237. DE SOUZA GP, Santos MM, Ferreira IN, Cunha JLS, et al
    Oral basaloid squamous cell carcinoma: A case report with emphasis on histopathological diagnosis criteria.
    Oral Oncol. 2022;127:105814.
    PubMed     Abstract available


  238. SEKAR D
    Implications of long non-coding RNAs (lncRNAs) in the treatment of oral squamous cell carcinoma (OSCC).
    Oral Oncol. 2022;127:105812.
    PubMed    


  239. TANS L, Al-Mamgani A, Kwa SLS, Elbers JBW, et al
    Single vocal cord irradiation for early-stage glottic cancer: Excellent local control and favorable toxicity profile.
    Oral Oncol. 2022;127:105782.
    PubMed     Abstract available


  240. BRINKMAN D, Callanan D, Jawad H, O'Sullivan R, et al
    Comparison of royal college of pathologists and college of american pathologists definition for positive margins in oral cavity squamous cell carcinoma.
    Oral Oncol. 2022;127:105797.
    PubMed     Abstract available


  241. ROH JL
    Gland-preserving surgery of benign parotid tumours via postauricular sulcus incision: Is it safe and effective with the scarless incision?
    Oral Oncol. 2022;127:105808.
    PubMed     Abstract available


  242. WANG SJ, Shen SY, Lin B, Wang F, et al
    Factors affecting postoperative sleep quality of patients undergoing flap transfer for head and neck reconstruction.
    Oral Oncol. 2022;127:105804.
    PubMed     Abstract available


  243. SARODE SC, Sarode GS, Sharma NK
    Salivary gland carcinomas and molecular chaos: Additional perspectives.
    Oral Oncol. 2022;127:105802.
    PubMed    


  244. SEKAR D
    The Role of microRNAs as a predictive biomarker and therapeutic molecule in the treatment of Oral Potentially Malignant Disorder (OPMD).
    Oral Oncol. 2022;127:105786.
    PubMed    


  245. LIN A, Helgeson ES, Treister NS, Schmidt BL, et al
    The impact of head and neck radiotherapy on salivary flow and quality of life: Results of the ORARAD study.
    Oral Oncol. 2022;127:105783.
    PubMed     Abstract available


  246. COMER JC, King RB, Harris AB, Hitchcock KE, et al
    Retromolar trigone squamous cell carcinoma: A population-based analysis of survival.
    Oral Oncol. 2022;127:105767.
    PubMed     Abstract available


  247. YANG Q, Cheng C, Zhu R, Guo F, et al
    A N6-methyladenosine-related long noncoding RNAs model for predicting prognosis in oral squamous cell carcinoma: Association with immune cell infiltration and tumor metastasis.
    Oral Oncol. 2022;127:105771.
    PubMed     Abstract available


  248. EGAL ESA, Scarini JF, de Lima-Souza RA, Lavareze L, et al
    Tumor microenvironment in salivary gland carcinomas: An orchestrated state of chaos.
    Oral Oncol. 2022;127:105777.
    PubMed     Abstract available


  249. DODDAWAD VG, Premalatha BR, Sreeshyla HS, Nitin P, et al
    Classification staging systems on clinical and radiographic features of inverted sinonasal papilloma: A case report.
    Oral Oncol. 2022;127:105768.
    PubMed     Abstract available


    March 2022
  250. PATIL V, Noronha V, Joshi A, Menon N, et al
    RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiation.
    Oral Oncol. 2022;128:105816.
    PubMed     Abstract available


  251. CHANG CT, Liu SP, Muo CH, Liao YF, et al
    The impact of dental therapy timelines and irradiation dosages on osteoradionecrosis in oral cancer patients: A population-based cohort study.
    Oral Oncol. 2022;128:105827.
    PubMed     Abstract available


  252. HSIEH MC, Wang CC, Yang CC, Lien CF, et al
    The role of induction chemotherapy in patients with locally advanced head and neck squamous cell carcinoma: A nationwide population-based matched study.
    Oral Oncol. 2022;128:105848.
    PubMed     Abstract available


  253. YANG X, Xu X, Zhang C, Ji T, et al
    The diagnostic value and prospects of gene mutations in circulating tumor DNA for head and neck cancer monitoring.
    Oral Oncol. 2022;128:105846.
    PubMed     Abstract available


  254. RANJAN MISRA S, Das R
    Tele-screening for early detection of oral cancer during the COVID-19 pandemic era: Diagnostic pitfalls and potential misinterpretations!
    Oral Oncol. 2022;128:105845.
    PubMed    


  255. MATTOX AK, D'Souza G, Khan Z, Allen H, et al
    Comparison of next generation sequencing, droplet digital PCR, and quantitative real-time PCR for the earlier detection and quantification of HPV in HPV-positive oropharyngeal cancer.
    Oral Oncol. 2022;128:105805.
    PubMed     Abstract available


  256. BALACHANDER K, Paramasivam A
    Cell-free mitochondrial DNA as a novel non-invasive biomarker for oral cancer.
    Oral Oncol. 2022;127:105825.
    PubMed    


  257. YAMAGUMA Y, Kaneuji T, Shirouzu S, Fukui T, et al
    Combination therapy of Mohs paste and chemotherapy improved metastatic oral cancer to the precordium skin and bilateral axillary lymph nodes: A case report.
    Oral Oncol. 2022;127:105817.
    PubMed     Abstract available


  258. VILLARD A, Breuskin I, Casiraghi O, Asmandar S, et al
    Confocal laser endomicroscopy and confocal microscopy for head and neck cancer imaging: Recent updates and future perspectives.
    Oral Oncol. 2022;127:105826.
    PubMed     Abstract available


  259. PATIL V, Alone M, Rai R, Noronha V, et al
    Safety and efficacy of pembrolizumab with chemotherapy in locally advanced head and neck cancers.
    Oral Oncol. 2022;127:105824.
    PubMed    


  260. DE LUCA P, Di Stadio A, Tassone D, de Campora L, et al
    Large cervical mass and head and neck cancer. First report of ectopic papillary adenoma of the lung.
    Oral Oncol. 2022;127:105823.
    PubMed     Abstract available


  261. DEVARAJA K, Kabekkodu SP
    Oral microbiome; a potential game-changer in the management of oral cancer?
    Oral Oncol. 2022;127:105822.
    PubMed    


  262. BONETTI VALENTE V, Mantovan Mazzon B, Urbano Collado F, Conrado Neto S, et al
    Clinicopathological and prognostic profile of non-smoking and non-drinking head and neck cancer patients: a population-based comparative study.
    Oral Oncol. 2022;127:105799.
    PubMed     Abstract available


  263. SHETH S, Gilbert J, Deal AM, Chera B, et al
    Mature follow up of induction chemotherapy with carboplatin, nab-paclitaxel, cetuximab in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;127:105807.
    PubMed    


  264. VALERO C, Yuan A, Zanoni DK, Lei E, et al
    Young non-smokers with oral cancer: What are we missing and why?
    Oral Oncol. 2022;127:105803.
    PubMed     Abstract available


  265. ELUMALAI P, Ezhilarasan D, Lakshmi T
    Targeting head and neck cancer epigenetics with CRISPR-dCas9: An emerging therapeutic approach.
    Oral Oncol. 2022;127:105801.
    PubMed    


  266. GLAZAR DJ, Johnson M, Farinhas J, Steuer CE, et al
    Early response dynamics predict treatment failure in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with cetuximab and nivolumab.
    Oral Oncol. 2022;127:105787.
    PubMed     Abstract available


  267. ROUTILA J, Qiao X, Weltner J, Rantala JK, et al
    Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma.
    Oral Oncol. 2022;127:105772.
    PubMed     Abstract available


  268. BRODY RM, Shimunov D, Cohen RB, Lin A, et al
    A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers.
    Oral Oncol. 2022;127:105798.
    PubMed     Abstract available


  269. GONCALVES JM, Scarini JF, Gondak R, Altemani A, et al
    Oral involvement of sinonasal undifferentiated carcinoma: A case report and immunohistochemical study of a challenging case.
    Oral Oncol. 2022;126:105779.
    PubMed     Abstract available


  270. I GHANEM A, Woody NM, Schymick MA, Joshi NP, et al
    Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative study.
    Oral Oncol. 2022;126:105781.
    PubMed     Abstract available


  271. LOMBARDI D, Tomasoni M, Lorini L, Gurizzan C, et al
    Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma.
    Oral Oncol. 2022;126:105764.
    PubMed     Abstract available


  272. CALABRESE L, Nocini R, Spirito F, Gazzini L, et al
    The role of the depth of invasion (DOI) in minor salivary glands tumors according to the 8th TNM classification: Pitfalls and potential misinterpretations.
    Oral Oncol. 2022;126:105751.
    PubMed    


  273. AL-LAMI A, Gao C, Saddiq M, Al Zuhir N, et al
    Reducing the unknowns: A systematic review & meta-analysis of the effectiveness of trans-oral surgical techniques in identifying head and neck primary cancer in carcinoma unknown primary.
    Oral Oncol. 2022;126:105748.
    PubMed     Abstract available


  274. SEKAR D
    Circulatory microRNAs inhibition and its signaling pathways in the treatment of oral squamous cell carcinoma (OSCC).
    Oral Oncol. 2022;126:105763.
    PubMed    


  275. SILVA LC, Faustino ISP, Cantadori GR, Santos-Silva AR, et al
    Adenocarcinoma not otherwise specified (NOS) arising in the sublingual gland: Rare case report and follow-up.
    Oral Oncol. 2022;126:105754.
    PubMed     Abstract available


  276. KANG CJ, Wen YW, Lee SR, Ng SH, et al
    Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study.
    Oral Oncol. 2022;126:105750.
    PubMed     Abstract available


  277. SAKTHIVEL P, Raveendran S, Rajeshwari M
    Sinonasal small round blue cell tumors: What the clinician must know!
    Oral Oncol. 2022;126:105735.
    PubMed    


  278. YUWANATI M, Sarode SC, Sarode GS, Gadbail A, et al
    Clinical trial outcomes in oral squamous cell carcinoma: A pragmatic ideation.
    Oral Oncol. 2022;126:105752.
    PubMed    


  279. CHAGAS-NETO JL, Nogueira DPS, Santos-Neto AGD, Duarte IX, et al
    Hyalinizing clear cell carcinoma of minor salivary glands: A case report with uncommon presentation.
    Oral Oncol. 2022;126:105753.
    PubMed     Abstract available


  280. E C, M D, K C, V A, et al
    Trismus therapy devices: A systematic review.
    Oral Oncol. 2022;126:105728.
    PubMed     Abstract available


  281. NAYYAR V, Bhutia O, Kakkar A, Mishra D, et al
    Primary intraosseous oncocytic mucoepidermoid carcinoma of the jaw: First case report.
    Oral Oncol. 2022;126:105732.
    PubMed    


  282. RAMOS-GARCIA P, Gonzalez-Moles MA, Warnakulasuriya S
    Significance of p53 overexpression in the prediction of the malignant transformation risk of oral potentially malignant disorders: A systematic review and meta-analysis.
    Oral Oncol. 2022;126:105734.
    PubMed     Abstract available


    February 2022
  283. QURESHI HA, Zhu X, Yang GH, Steadele M, et al
    Impact of HPV status on immune responses in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;127:105774.
    PubMed     Abstract available


  284. BELGIOIA L, Becherini C, Bacigalupo A, Bonomo P, et al
    Chemo- immunotherapy and radiation in locally advanced head and neck cancer: Where do we stand?
    Oral Oncol. 2022;127:105773.
    PubMed     Abstract available


  285. DAGLINAMRATA, Lakshmi T, Rushabh D, Dineshkumar T, et al
    Telescreening as an alternate modality for early detection of oral cancer.
    Oral Oncol. 2022;127:105785.
    PubMed    


  286. HARING CT, Dermody SM, Yalamanchi P, Kang SY, et al
    The future of circulating tumor DNA as a biomarker in HPV related oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2022;126:105776.
    PubMed     Abstract available


  287. MICHMERHUIZEN NL, Heenan C, Wang J, Leonard E, et al
    Combined Pik3ca-H1047R and loss-of-function Notch1 alleles decrease survival time in a 4-nitroquinoline N-oxide-driven head and neck squamous cell carcinoma model.
    Oral Oncol. 2022;126:105770.
    PubMed    


  288. MADY LJ, Baddour K, Hodges JC, Magana LC, et al
    The impact of frailty on mortality in non-surgical head and neck cancer treatment: Shifting the clinical paradigm.
    Oral Oncol. 2022;126:105766.
    PubMed     Abstract available


  289. ZHANG S, Zhang W, Zhang J
    Comprehensive analysis of immune cell infiltration and significant genes in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;126:105755.
    PubMed     Abstract available


  290. LI JL, Hsieh TL, Ou MC, Lin FC, et al
    Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio during immune checkpoint inhibitor treatment in recurrent or metastatic head and neck squamous cell carcinoma patients.
    Oral Oncol. 2022;126:105729.
    PubMed    


  291. LENOCI D, Carenzo A, Cavalieri S, Pistore F, et al
    Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials.
    Oral Oncol. 2022;126:105756.
    PubMed    


  292. CHAN SK, Lin C, Huang SH, Chau TC, et al
    Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma.
    Oral Oncol. 2022;126:105736.
    PubMed     Abstract available


  293. VAN MUNSTER MH, de Bree R, Breimer GE, Van Cann EM, et al
    Surgical margins in the resection of oral squamous cell carcinoma under local versus general anesthesia.
    Oral Oncol. 2022;125:105724.
    PubMed     Abstract available


  294. KRISHNA A, Singh S, Kumar V
    Prognostic impact of Beta-2 Adrenergic Receptor in oral squamous cell carcinoma.
    Oral Oncol. 2022;125:105720.
    PubMed    


  295. SILVERMAN DA, Parikh AS, Liu K, Zhan KY, et al
    Predictors of survival following carotid blowout syndrome.
    Oral Oncol. 2022;125:105723.
    PubMed     Abstract available


  296. ZOTTI F, Nocini R, Capocasale G, Fior A, et al
    Response to a Comment on "Malignant transformation evidences of Oral Lichen Planus: When the time is of the essence".
    Oral Oncol. 2022;125:105714.
    PubMed    


  297. TEZ M
    Chronic mechanical irritation and oral squamous cell carcinoma: Let's look from evolutionary perspective.
    Oral Oncol. 2022;125:105727.
    PubMed    


  298. GANAPATHY D, Ramadoss R, Yuwanati M, Karthikeyan M, et al
    Rarity of mucormycosis in oral squamous cell carcinoma: A clinical paradox?
    Oral Oncol. 2022;125:105725.
    PubMed    


  299. CHIN O, Alshafai L, O'Sullivan B, Su J, et al
    Inter-rater concordance and operating definitions of radiologic nodal feature assessment in human papillomavirus-positive oropharyngeal carcinoma.
    Oral Oncol. 2022;125:105716.
    PubMed     Abstract available


  300. FAUSTINO ISP, Georgaki M, Santos-Silva AR, Vargas PA, et al
    Head and neck radiotherapy leading to extensive late oral soft-tissue necrosis.
    Oral Oncol. 2022;125:105710.
    PubMed     Abstract available


  301. MENDEZ AI, Wihlidal JGJ, Eurich DT, Nichols AC, et al
    Validity of functional patient-reported outcomes in head and neck oncology: A systematic review.
    Oral Oncol. 2022;125:105701.
    PubMed     Abstract available


  302. SARODE G, Sarode SC, Sharma NK
    Phenotypic reflection of white sponge nevus in histomorphological features of oral squamous cell carcinoma.
    Oral Oncol. 2022;125:105707.
    PubMed    


  303. MISRA SR, Mishra N, Satpathy SK
    Primary oral melanoma: ABCDE or AEIOU criteria for clinical diagnosis?
    Oral Oncol. 2022;125:105706.
    PubMed    


  304. VAN WEERT S, Valstar M, Lissenberg-Witte B, Bloemena E, et al
    Prognostic factors in acinic cell carcinoma of the head and neck: The Amsterdam experience.
    Oral Oncol. 2022;125:105698.
    PubMed     Abstract available


  305. CHEN TC, Wang C, Su LY, Lin MC, et al
    Impact of invasion into cervical esophagus for patients with hypopharyngeal squamous cell carcinoma.
    Oral Oncol. 2022;125:105683.
    PubMed     Abstract available


  306. SAWHNEY S, Thiagarajan S, Balaji A, Sathe P, et al
    Results of sequential swallowing assessments in patients undergoing upfront surgery for oral tongue squamous cell carcinoma.
    Oral Oncol. 2022;125:105684.
    PubMed     Abstract available


  307. FERREIRA PS, Rocha L, Bezerra APC, Nico MMS, et al
    Reflectance confocal microscopy (RCM)-based criteria for progression of lower-lip squamous cell carcinoma: A prospective study.
    Oral Oncol. 2022;125:105674.
    PubMed     Abstract available


    January 2022
  308. SENGUPTA N, Sarode SC, Sarode GS, Ghone U, et al
    Scarcity of publicly available oral cancer image datasets for machine learning research.
    Oral Oncol. 2022;126:105737.
    PubMed     Abstract available


  309. JONAS H, Simnica D, Bussmann L, Zech H, et al
    Early relapse detection by monitoring of circulating cell-free DNA in patients with localized head and neck squamous cell carcinoma: A subgroup analysis of the multicenter randomized clinical trial IMSTAR-HN.
    Oral Oncol. 2022;126:105733.
    PubMed    


  310. SEKAR D
    Inhibition of OSCC derived ExomiRs and its therapeutic applications in oral cancer.
    Oral Oncol. 2022;126:105747.
    PubMed    


  311. FERRAZZO KL
    Regarding: "Clinical practice guidelines for dental management prior to radiation for head and neck cancer".
    Oral Oncol. 2022;126:105731.
    PubMed    


  312. WARD MC, Miller JA, Walker GV, Moeller BJ, et al
    The economic impact of circulating tumor-tissue modified HPV DNA for the post-treatment surveillance of HPV-driven oropharyngeal cancer: A simulation.
    Oral Oncol. 2022;126:105721.
    PubMed     Abstract available


  313. LIU X, Li WF, Ding C, Chen L, et al
    Differential benefit of induction chemotherapy according to body mass index in nasopharyngeal carcinoma - Pooled analysis of two randomized trials.
    Oral Oncol. 2022;125:105718.
    PubMed     Abstract available


  314. K AP, Selvakumar SC, Selvaraj J, Mony U, et al
    Reviewing the potential application of miR-21 inhibitors in oral cancer therapeutics.
    Oral Oncol. 2022;125:105713.
    PubMed    


  315. ECONOMOPOULOU P, Kotsantis I, Psyrri A
    Radiotherapy and immunotherapy combination in head and neck cancer: Does current failure qualify as an ending or is it a key to future success?
    Oral Oncol. 2022 Jan 13:105717. doi: 10.1016/j.oraloncology.2022.105717.
    PubMed    


  316. CARDIN GB, Bernard M, Bourbonnais J, Bahig H, et al
    The rs6942067 genotype is associated with a worse overall survival in young or non-smoking HPV-negative patients with positive nodal status in head and neck squamous cell carcinoma.
    Oral Oncol. 2022;125:105696.
    PubMed    


  317. GILLIGAN G, Piemonte E, Lazos J, Panico R, et al
    Chronic wounds of traumatic origin and oral cancer arising de novo: A potential association?
    Oral Oncol. 2022;125:105711.
    PubMed    


  318. PATIL V, Ghandade N, Noronha V, Menon N, et al
    Hypomagnesemia in patients with locally advanced head and neck cancer treated weekly cisplatin-incidence and impact on outcomes.
    Oral Oncol. 2022;125:105709.
    PubMed    


  319. D'ASCANIO L, Latini G, Pandolfini M, Imperatori L, et al
    Covid-19 negatively impacted on small oncology surgery but none on major procedures: Regional experience.
    Oral Oncol. 2022;124:105439.
    PubMed     Abstract available


  320. RAMDOSS R, Yuwanati M, Viola E A, Ramani P, et al
    Can koilocytes without dysplasia in OPMDs be an early indicator and prognostic factor for oral squamous cell carcinoma?
    Oral Oncol. 2022;124:105672.
    PubMed    


  321. SARODE GS, Sarode SC, Yuwanati M, Gadbail A, et al
    Lichenoid infiltrate in oral submucous fibrosis: A new marker of malignant transformation.
    Oral Oncol. 2022;124:105671.
    PubMed    


  322. SANTANA T, Correia Neto IJ, Sugaya NN, Trierveiler M, et al
    Myoepithelial carcinoma of the minor salivary glands: A case report of a rare tumor.
    Oral Oncol. 2022;124:105667.
    PubMed    


  323. VIITASALO S, Karhemo PR, Vaananen J, Ilmarinen T, et al
    Exome sequencing reveals candidate mutations implicated in sinonasal carcinoma and malignant transformation of sinonasal inverted papilloma.
    Oral Oncol. 2022;124:105663.
    PubMed     Abstract available


  324. PANTA P, Misra SR
    Chronic mechanical irritation and oral squamous cell carcinoma: A case series.
    Oral Oncol. 2022;124:105669.
    PubMed    


  325. XAVIER-JUNIOR JCC, Ocanha-Xavier JP, Asato MA, Bernabe DG, et al
    The 'AEIOU' system to identify primary oral melanoma.
    Oral Oncol. 2022;124:105670.
    PubMed     Abstract available


  326. SAKTHIVEL P, Thakar A, Fernandez-Fernandez MM, Panda S, et al
    TransOral UltraSonic surgery (TOUSS) for oral cavity, oropharyngeal and supraglottic malignancy: A prospective study of feasibility, safety, margins, functional and survival outcomes.
    Oral Oncol. 2022;124:105643.
    PubMed     Abstract available


  327. KIM TH, Eun YG, Lee YC
    A machine learning based survival prediction model for advanced parotid gland mucoepidermoid carcinoma.
    Oral Oncol. 2022;124:105664.
    PubMed    


  328. MISRA SR, Das R
    Comment on "Oral squamous cell carcinoma due to chronic mechanical irritation."
    Oral Oncol. 2022;124:105661.
    PubMed    


  329. DE FELICE F, Botticelli A
    Cetuximab: Its role in patients unfit for cisplatin.
    Oral Oncol. 2022;124:105654.
    PubMed    


  330. ZANONI DK, Valero C, McGill MR, Montero PH, et al
    Distant metastasis in oral squamous cell carcinoma: Does the neutrophil-to-lymphocyte ratio act as a surrogate of the host immune status?
    Oral Oncol. 2022;124:105641.
    PubMed     Abstract available


  331. ABBASI AI, Shetty SS, de Arruda JAA
    Autotransplantation of teeth: An alternative for patients with malignant transformation of oral submucous fibrosis.
    Oral Oncol. 2022;124:105644.
    PubMed    


  332. LI MM, Mroz EA, Faquin WC, Lott-Limbach A, et al
    ERalpha: A biomarker and treatment target for oropharyngeal cancer?
    Oral Oncol. 2022;124:105637.
    PubMed    


  333. RAMADOSS R, Yuwanati M, Ramani P, Krishnan R, et al
    Glandular metaplasia in oral squamous cell carcinoma: Prognostic indicators? Deriving inference from urothelial and breast carcinoma.
    Oral Oncol. 2022;124:105639.
    PubMed    


  334. FAKHRAEI S, Layegh P, Darchini-Maragheh E, Tayyebi Meybodi N, et al
    Oral verrucous carcinoma arising from pemphigus vulgaris: A rare coincidence.
    Oral Oncol. 2022;124:105513.
    PubMed    


  335. MALIK A, Panda S, Sakthivel P
    Treatment of early glottic carcinoma: Is it a paradox of choices?
    Oral Oncol. 2022;124:105516.
    PubMed    


  336. PANDIAR D, Ramani P, Krishnan RP, Thamilselvan S, et al
    Spindle cell squamous cell carcinoma of alveolus with heterologous mesenchymal differentiation and synchronous contralateral buccal squamous cell carcinoma in a background of oral submucous fibrosis: Recapitulation of embryonic plasticity?
    Oral Oncol. 2022;124:105476.
    PubMed    


  337. VARGHESE BT
    Head and neck surgical oncology training in the current era of molecular oncology.
    Oral Oncol. 2022;124:105474.
    PubMed     Abstract available


  338. ZHANG L, Chen L, Xiao M, Xie X, et al
    Locally advanced undifferentiated sarcomatoid carcinoma of the right maxillary sinus with PDCD6-TERT fusion: A rare case report.
    Oral Oncol. 2022;124:105466.
    PubMed     Abstract available


    December 2021
  339. COHEN O, Brauer PR, Judson BL, Burtness BA, et al
    Guideline - Adherence in advanced stage head and neck cancer is associated with improved survival - A National study.
    Oral Oncol. 2021;125:105694.
    PubMed     Abstract available


  340. WANG J, Tian Y, Huang H, Huang D, et al
    The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site.
    Oral Oncol. 2021;125:105675.
    PubMed     Abstract available


  341. SUBASH A, Bylapudi B, Thakur S, Rao VUS, et al
    Oral cancer in India, a growing problem: Is limiting the exposure to avoidable risk factors the only way to reduce the disease burden?
    Oral Oncol. 2021;125:105677.
    PubMed     Abstract available


  342. MERCHANT YP, Mohan M, Shetty S, Bandemegal M, et al
    The submandibular gland in neck dissection: A necessary casualty or a hapless victim?
    Oral Oncol. 2021;125:105678.
    PubMed    


  343. HERNDON P, Jassal JS, Cramer JD
    Association between E-cigarette use and oral HPV-16 infection.
    Oral Oncol. 2021;125:105676.
    PubMed    


  344. DOU Y, Ma C, Wang K, Liu S, et al
    Dysbiotic tumor microbiota associates with head and neck squamous cell carcinoma outcomes.
    Oral Oncol. 2021;124:105657.
    PubMed     Abstract available


  345. NOJI R, Kano Y, Hirai H, Onishi I, et al
    MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma.
    Oral Oncol. 2021;124:105666.
    PubMed     Abstract available


  346. WEI LY, Lin HC, Tsai FC, Ko JY, et al
    Effects of Interleukin-6 on STAT3-regulated signaling in oral cancer and as a prognosticator of patient survival.
    Oral Oncol. 2021;124:105665.
    PubMed     Abstract available


  347. SARI SY, Yilmaz MT, Aktas BY, Aksoy S, et al
    Results of concurrent radiotherapy and immunotherapy in recurrent and metastatic head and neck cancer: A single-center experience.
    Oral Oncol. 2021;124:105658.
    PubMed     Abstract available


  348. CRAMER JD, Grauer J
    Modeling oral cancer screening in the United States population.
    Oral Oncol. 2021;124:105656.
    PubMed     Abstract available


  349. BIGELOW EO, Windon MJ, Fakhry C, Kiess AP, et al
    Development of a web-based, patient-centered decision aid for oropharyngeal cancer treatment.
    Oral Oncol. 2021;123:105618.
    PubMed     Abstract available


  350. CAI X, Zhang J, Han Y, Tang Q, et al
    Development and validation of a nomogram prediction model for malignant transformation of oral potentially malignant disorders.
    Oral Oncol. 2021;123:105619.
    PubMed     Abstract available


  351. ROMINE PE, Voutsinas J, Wu V, Tratt M, et al
    Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution.
    Oral Oncol. 2021;123:105626.
    PubMed     Abstract available


  352. BURNINGHAM K, Moore W, Moon D, Avkshtol V, et al
    Prognostic impact of matted lymphadenopathy in patients with oropharyngeal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Oral Oncol. 2021;123:105623.
    PubMed     Abstract available


  353. GHONE U, Sarode GS, Sengupta N, Sarode SC, et al
    Oral potentially malignant disorder and regular follow-up: Importance well understood with poor translation.
    Oral Oncol. 2021;123:105630.
    PubMed    


  354. MISHRA S, Thakur S, Rao VUS, Subash A, et al
    Failure rate in the untreated contralateral node negative neck of small lateralized oral cavity cancers: A multi-institutional collaborative study.
    Oral Oncol. 2021;123:105614.
    PubMed    


  355. BYLAPUDI B, Rao VUS, Subash A, Thakur S, et al
    Does SLNB substitute END in the future with the sole advantage of preventing shoulder morbidity?
    Oral Oncol. 2021;123:105628.
    PubMed     Abstract available


  356. BERGER J, Zech HB, Hoffer K, von Bargen CM, et al
    Kinomic comparison of snap frozen and ex vivo-cultured head and neck tumors.
    Oral Oncol. 2021;123:105603.
    PubMed     Abstract available


  357. NOEL CW, Forner D, Chepeha DB, Baran E, et al
    The Edmonton Symptom Assessment System: A narrative review of a standardized symptom assessment tool in head and neck oncology.
    Oral Oncol. 2021;123:105595.
    PubMed     Abstract available


  358. CHENG NM, Kang CJ, Tsai CY, Lee LY, et al
    Improved prognostic stratification of patients with pN3b oral cavity cancer based on maximum standardized uptake value of metastatic nodes, lymph node ratio, and level of cervical nodal metastases.
    Oral Oncol. 2021;123:105593.
    PubMed     Abstract available


  359. MIMICA X, Yuan A, Hay A, Katabi N, et al
    Mucoepidermoid carcinoma: Evaluating the prognostic impact of primary tumor site.
    Oral Oncol. 2021;123:105602.
    PubMed     Abstract available


  360. SIVANANDAN N, Nagarajan M, Roy A, Subramaniam A, et al
    Invasive oral squamous cell carcinoma of maxillary alveolus in a Nicobari tribal woman after 17 years of tobacco cessation - A case report.
    Oral Oncol. 2021;123:105601.
    PubMed    


  361. PANTA P
    Oral squamous cell carcinoma due to chronic mechanical irritation.
    Oral Oncol. 2021;123:105616.
    PubMed    


  362. VAN DER WAAL I
    The term 'Proliferative verrucous leukoplakia' should be abandoned and this is why.
    Oral Oncol. 2021;123:105621.
    PubMed    


  363. FUSSEY J, Tomasoni M, Tirelli G, Giordano L, et al
    Prognostic indicators in clinically node-negative malignant primary salivary tumours of the parotid: A multicentre experience.
    Oral Oncol. 2021;123:105577.
    PubMed     Abstract available


  364. VARGHESE BT
    Rearterialized islanded facial artery muco-muscular flap (iFAMM) flap in tongue reconstruction.
    Oral Oncol. 2021;123:105592.
    PubMed    


  365. LIU S, Bellile E, Nguyen A, Zarins K, et al
    Characterization of the immune response in patients with cancer of the oral cavity after neoadjuvant immunotherapy with the IRX-2 regimen.
    Oral Oncol. 2021;123:105587.
    PubMed     Abstract available


  366. JIMENEZ JE, Nilsen ML, Gooding WE, Anderson JL, et al
    Surgical factors associated with patient-reported quality of life outcomes after free flap reconstruction of the oral cavity.
    Oral Oncol. 2021;123:105574.
    PubMed     Abstract available


  367. MERCHANT YP, Subash A, Rao VUS
    Unravelling parotid metastasis in oral squamous cell carcinoma - Do they warrant inclusion in Staging?
    Oral Oncol. 2021;123:105581.
    PubMed    


  368. ARUN P, Arun I, Jain P, Manikantan K, et al
    Determinants of prognosis in patients with oral squamous cell carcinoma metastasizing to a single cervical lymph node.
    Oral Oncol. 2021;123:105586.
    PubMed     Abstract available


  369. ASODA S, Miyashita H, Soma T, Munakata K, et al
    Clinical value of entire-circumferential intraoperative frozen section analysis for the complete resection of superficial squamous cell carcinoma of the tongue.
    Oral Oncol. 2021;123:105629.
    PubMed     Abstract available


    November 2021
  370. GUPTA T, Maheshwari G, Kannan S, Nair S, et al
    Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharyngeal squamous cell carcinoma: Evidence-base for pract
    Oral Oncol. 2021;124:105642.
    PubMed     Abstract available


  371. CHAUHAN A, Kaur R, Ghoshal S, Chatterjee D, et al
    Potential prognostic and predictive role of baseline circulating tumor cells in head and neck squamous cell carcinoma.
    Oral Oncol. 2021;124:105636.
    PubMed    


  372. FUEREDER T, Minichsdorfer C, Mittlboeck M, Wagner C, et al
    Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II study.
    Oral Oncol. 2021;124:105634.
    PubMed     Abstract available


  373. DENARO N, Merlano M, Garrone O
    In reply to immune desert in head and neck squamous cell carcinoma: A review of challenges and opportunities for modulating the tumor immune microenvironment.
    Oral Oncol. 2021;124:105640.
    PubMed    


  374. THADURI A, Dungala D, Panuganti A, Majumdar KS, et al
    Addressing the challenges of head and neck cancer care in India - A compelling need of the hour.
    Oral Oncol. 2021;124:105638.
    PubMed    


  375. MADHULAXMI M, Abhinav RP
    Protein changes of WNT signaling pathway in oral cancer.
    Oral Oncol. 2021;123:105624.
    PubMed    


  376. KOWALCHUK RO, Van Abel KM, Yin LX, Garcia J, et al
    Correlation between radiographic and pathologic lymph node involvement and extranodal extension via CT and PET in HPV-associated oropharyngeal cancer.
    Oral Oncol. 2021;123:105625.
    PubMed     Abstract available


  377. GAU M, Fonseca A, Ozsahin M, Fayette J, et al
    Prognostic impact of extranodal extension in resected head and neck squamous cell carcinomas in the era of postoperative chemoradiation: A retrospective monocentric study.
    Oral Oncol. 2021;123:105605.
    PubMed     Abstract available


  378. MISHRA S, Subash A, Rao VUS, Thakur S, et al
    Role of neoadjuvant chemotherapy in head and neck cancer management: A case for exploring diverse treatment strategies for evaluating long-term efficacy.
    Oral Oncol. 2021;123:105594.
    PubMed    


  379. GOLUSINSKI P, Corry J, Poorten VV, Simo R, et al
    De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?
    Oral Oncol. 2021;123:105620.
    PubMed     Abstract available


  380. WATSON E, Dorna Mojdami Z, Oladega A, Hope A, et al
    Clinical practice guidelines for dental management prior to radiation for head and neck cancer.
    Oral Oncol. 2021;123:105604.
    PubMed     Abstract available


  381. BRIL SI, Chargi N, Wendrich AW, Wegner I, et al
    Validation of skeletal muscle mass assessment at the level of the third cervical vertebra in patients with head and neck cancer.
    Oral Oncol. 2021;123:105617.
    PubMed     Abstract available


  382. WANG Y, Gao Y, Yuan L, Zhang J, et al
    Psychological needs and associated factors among perioperative patients with oral cancer.
    Oral Oncol. 2021;123:105615.
    PubMed    


  383. JOY A, Rao VUS
    Reply: Nodal yield and topography of nodal metastases from oral cavity squamous cell carcinoma - An audit of 1004 cases undergoing primary surgical resection.
    Oral Oncol. 2021;122:105535.
    PubMed    


  384. SHAH A, Sumer BD, Schostag K, Balachandra S, et al
    Institutional patterns of head and neck oncology care during the early phase of the COVID-19 pandemic: A retrospective, pooled cross-sectional analysis.
    Oral Oncol. 2021;122:105564.
    PubMed    


  385. LIAO CT, Yang LY, Lee LY, Lin CY, et al
    Whole-exome sequencing identifies biosignatures that predict adverse survival outcomes in surgically treated patients with oral cavity squamous cell carcinoma.
    Oral Oncol. 2021;122:105547.
    PubMed     Abstract available


  386. GRONLUND MP, Jakobsen KK, Mirian C, Gronhoj C, et al
    Nasopharyngeal malignancies in Denmark diagnosed from 1980 to 2014.
    Oral Oncol. 2021;122:105583.
    PubMed     Abstract available


  387. YU J, Tsay C, Sasaki C, Son YH, et al
    Brachytherapy and non-cancer mortality in patients with oral cavity and oropharynx SCCs.
    Oral Oncol. 2021;122:105585.
    PubMed     Abstract available


  388. SEE A, Chu C, Kiong KL, Teo C, et al
    Surgical salvage of recurrent nasopharyngeal cancer- a multi-institutional review.
    Oral Oncol. 2021;122:105556.
    PubMed    


  389. SAKTHIVEL P, Ramanikanth TV, Thakar A, Singh CA, et al
    TransOral UltraSonic Surgery (TOUSS) assisted supraglottic laryngectomy: Expanding the spectrum of endoscopic head and neck surgeries.
    Oral Oncol. 2021;122:105562.
    PubMed    


  390. RODRIGUES-FERNANDES CI, Arboleda LPA, Vargas PA, Lopes MA, et al
    Oral leukoplakia in adolescents: Report of a rare case and review of the literature.
    Oral Oncol. 2021;122:105565.
    PubMed     Abstract available


  391. THAKAR A, Sakthivel P, Sikka K
    TransOral UltraSonic Surgery (TOUSS) and TransOral Laser (TOL) assisted supraglottic laryngectomy (TOUSS-TOL-SGL): Improvising techniques within the transoral corridor.
    Oral Oncol. 2021;122:105573.
    PubMed    


  392. LIU W, Zhu L, Xu L, Wu L, et al
    Exophytic verrucous hyperplasia as a clinical terminology includes verrucous hyperplasia with or without epithelial dysplasia in histology.
    Oral Oncol. 2021;122:105571.
    PubMed    


  393. LIN N, Gao J, Wang H, Zhang H, et al
    Diagnostic value of indocyanine green for sentinel lymph node mapping and lymph node metastasis in oral/oropharyngeal carcinoma.
    Oral Oncol. 2021;122:105563.
    PubMed     Abstract available


  394. RE M, Tomasetti M, Monaco F, Amati M, et al
    NGS-based miRNome identifies miR-449 cluster as marker of malignant transformation of sinonasal inverted papilloma.
    Oral Oncol. 2021;122:105554.
    PubMed     Abstract available


  395. MCDOWELL L, Casswell G, Bressel M, Drosdowsky A, et al
    Symptom burden, quality of life, functioning and emotional distress in survivors of human papillomavirus associated oropharyngeal cancer: An Australian cohort.
    Oral Oncol. 2021;122:105560.
    PubMed     Abstract available


  396. MIN PARK Y, Yol Lim J, Woo Koh Y, Kim SH, et al
    Prediction of treatment outcome using MRI radiomics and machine learning in oropharyngeal cancer patients after surgical treatment.
    Oral Oncol. 2021;122:105559.
    PubMed     Abstract available


  397. SANTANA T, Custodio M, Dayla Melo Oliveira C, Dos Santos Antunes E, et al
    Parotid metastasis of clear cell renal cell carcinoma 8 years after nephrectomy.
    Oral Oncol. 2021;122:105561.
    PubMed    


  398. SHIKDAR S, Fowle E, Razaq H, Razaq W, et al
    Hormonal receptor evaluation in salivary duct adenocarcinoma.
    Oral Oncol. 2021;122:105548.
    PubMed    


  399. FERRELI F, Festa BM, Costantino A, Malvezzi L, et al
    Prevalence of occult level 2b nodal metastases in cN0 squamous cell carcinoma of the oral cavity: A systematic review and meta-analysis.
    Oral Oncol. 2021;122:105540.
    PubMed     Abstract available


  400. SINGH GK, Patil VM, Noronha V, Joshi A, et al
    Weight loss and its impact on outcome in head and cancer patients during chemo-radiation.
    Oral Oncol. 2021;122:105522.
    PubMed     Abstract available


  401. VAN LE Q, Ngo DQ, Nguyen HX, Ngo QX, et al
    Transoral robotic thyroidectomy: First case as a new technique in Vietnam.
    Oral Oncol. 2021;122:105542.
    PubMed    


  402. BULBUL MG, Tarabichi O, Parikh AS, Yoon BC, et al
    The utility of intra-oral ultrasound in improving deep margin clearance of oral tongue cancer resections.
    Oral Oncol. 2021;122:105512.
    PubMed     Abstract available


  403. PATEL V, Galloway TJ, Liu JC
    The impact of positive margin on survival in oral cavity squamous cell carcinoma.
    Oral Oncol. 2021;122:105499.
    PubMed     Abstract available


    October 2021
  404. GEORGE A, Saseendran A, Joseph ST, Gopal KR, et al
    Submandibular gland - The victim of neck dissection.
    Oral Oncol. 2021;123:105591.
    PubMed    


  405. CABEZAS-CAMARERO S, Alonso-Ovies A, Merino-Menendez S, Cabrera-Martin MN, et al
    Major pathological response and durable locoregional control after neoadjuvant pembrolizumab-carboplatin-paclitaxel in head and neck cancer.
    Oral Oncol. 2021;123:105589.
    PubMed     Abstract available


  406. BRUIJNEN CP, de Groot LGR, Vondeling AM, de Bree R, et al
    Functional decline after surgery in older patients with head and neck cancer.
    Oral Oncol. 2021;123:105584.
    PubMed     Abstract available


  407. PUTHIYOTTIL IV, Subash A, Thakur S, Rao VUS, et al
    Elective neck dissection versus sentinel node biopsy in early oral cavity cancer - Are we ready for transition?
    Oral Oncol. 2021;123:105597.
    PubMed    


  408. SHINN JR, Carey RM, Mady LJ, Shimunov D, et al
    Sex-based differences in outcomes among surgically treated patients with HPV-related oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2021;123:105570.
    PubMed     Abstract available


  409. JOSE MARTELLI A, Assis Machado R, Medeiros Pereira W, Balduino Guimaraes Santos F, et al
    Revaluation of the treatment of head and neck cancer in Brazil during the COVID-19 pandemic - phase 2.
    Oral Oncol. 2021;123:105600.
    PubMed    


  410. YUWANATI M, Sarode SC, Gadbail A, Gondivkar S, et al
    Alcohol attributed Oral Cancer and Oral microbiome: Emerging yet neglected research domain.
    Oral Oncol. 2021;123:105596.
    PubMed    


  411. YU ST, Ge JN, Sun BH, Wei ZG, et al
    Lymph node yield in the initial central neck dissection (CND) associated with the risk of recurrence in papillary thyroid cancer: A reoperative CND cohort study.
    Oral Oncol. 2021;123:105567.
    PubMed     Abstract available


  412. SHU L, Wang D, Nannapaneni S, Sun Y, et al
    Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and neck squamous cell carcinoma cancer (HNSCC).
    Oral Oncol. 2021;122:105546.
    PubMed     Abstract available


  413. MA D, Orner D, Ghaly MM, Parashar B, et al
    Automated health chats for symptom management of head and neck cancer patients undergoing radiation therapy.
    Oral Oncol. 2021;122:105551.
    PubMed     Abstract available


  414. SHISHODIA G, Toledo RRG, Rong X, Zimmerman E, et al
    4NQO enhances differential activation of DNA repair proteins in HPV positive and HPV negative HNSCC cells.
    Oral Oncol. 2021;122:105578.
    PubMed     Abstract available


  415. ZHAO Y, Li WF, Li QJ, He SW, et al
    WIPI-1 inhibits metastasis and tumour growth via the WIPI-1-TRIM21 axis and MYC regulation in nasopharyngeal carcinoma.
    Oral Oncol. 2021;122:105576.
    PubMed     Abstract available


  416. ROSENBERG AJ, Agrawal N, Pearson A, Gooi Z, et al
    Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience.
    Oral Oncol. 2021;122:105566.
    PubMed     Abstract available


  417. TSENG WH, Li TH, Chiu HL, Yang TL, et al
    Long-term swallowing-related outcomes in oral cancer patients receiving proactive swallowing therapy.
    Oral Oncol. 2021;122:105569.
    PubMed     Abstract available


  418. BRIL SI, van Beers MA, Chargi N, Carrillo Minulina N, et al
    Skeletal muscle mass at C3 is a strong predictor for skeletal muscle mass at L3 in sarcopenic and non-sarcopenic patients with head and neck cancer.
    Oral Oncol. 2021;122:105558.
    PubMed    


  419. PENG H, Chen L, Mao YP, Tian L, et al
    Nomogram-aided individual induction chemotherapy regimen selection in advanced nasopharyngeal carcinoma.
    Oral Oncol. 2021;122:105555.
    PubMed     Abstract available


  420. OZER NE, Ilhan B, Guneri P
    Patient specific follow-up to monitor the risk of malignant transformation on oral mucosa.
    Oral Oncol. 2021;121:105300.
    PubMed    


  421. CARNEVALE C, Pagan-Pomar A, Bianchi A, Sarria-Echegaray P, et al
    Right colonic interposition for severe pharyngoesophageal stricture in head and neck patients: A feasible rescue strategy after multiple failed reconstructive options.
    Oral Oncol. 2021;121:105481.
    PubMed     Abstract available


  422. HANS S, Chebib E, Chekkoury-Idrissi Y, Distinguin L, et al
    Surgical and oncological outcomes of transoral robotic total laryngectomy: A case series.
    Oral Oncol. 2021;121:105511.
    PubMed     Abstract available


  423. MOFFA A, Giorgi L, Costantino A, De Benedetto L, et al
    Accuracy of autofluorescence and chemiluminescence in the diagnosis of oral Dysplasia and Carcinoma: A systematic review and Meta-analysis.
    Oral Oncol. 2021;121:105482.
    PubMed     Abstract available


  424. LIU W, Yang X, Shen Z, Shi L, et al
    The characteristics and prospects of reflectance confocal microscopy for noninvasive diagnosis of oral potentially malignant disorders.
    Oral Oncol. 2021;121:105479.
    PubMed    


  425. BOUCHER A, Ezzat S, Hotte S, Rachinsky I, et al
    Canadian consensus statement on the management of radioactive iodine-resistant differentiated thyroid cancer.
    Oral Oncol. 2021;121:105477.
    PubMed     Abstract available


  426. CHEN HB, Gong XY, Li W, Chen DS, et al
    Genomic landscape and tumor mutation burden analysis of Chinese patients with sarcomatoid carcinoma of the head and neck.
    Oral Oncol. 2021;121:105436.
    PubMed     Abstract available


  427. PARK JO, Lee DH, Kim MR, Kim SY, et al
    Transoral endoscopic thyroidectomy using a self-retaining retractor as an alternative to carbon dioxide gas insufflation: A comparative analysis of 131 cases.
    Oral Oncol. 2021;121:105463.
    PubMed     Abstract available


  428. CHAMOLI A, Gosavi AS, Shirwadkar UP, Wangdale KV, et al
    Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics.
    Oral Oncol. 2021;121:105451.
    PubMed     Abstract available


  429. FINEGERSH A, Voora RS, Panuganti B, Faraji F, et al
    Robotic surgery may improve overall survival for T1 and T2 tumors of the hypopharynx: An NCDB cohort study.
    Oral Oncol. 2021;121:105440.
    PubMed     Abstract available


  430. GILVETTI C, Soneji C, Bisase B, Barrett AW, et al
    Recurrence and malignant transformation rates of high grade oral epithelial dysplasia over a 10 year follow up period and the influence of surgical intervention, size of excision biopsy and marginal clearance in a UK regional maxillofacial surgery uni
    Oral Oncol. 2021;121:105462.
    PubMed     Abstract available


  431. LI Y, Gong L, Qin N, Wei X, et al
    Comprehensive analysis of circRNA expression pattern and circRNA-miRNA-mRNA network in oral squamous cell carcinoma.
    Oral Oncol. 2021;121:105437.
    PubMed     Abstract available


  432. WU T, Liu Z, Yong X, Mei G, et al
    P16-positive secondary tongue squamous cell carcinoma following allogeneic hematopoietic stem cell transplantation: A case report and literature review.
    Oral Oncol. 2021;121:105399.
    PubMed     Abstract available


  433. AL MASALMEH N, Kukreja G, Zaiem F, Raza SN, et al
    p16 positive oropharyngeal small cell cancer: A case report.
    Oral Oncol. 2021;121:105391.
    PubMed     Abstract available


  434. PANDIAR D, Ramani P, Krishnan RP, Monica K, et al
    Multifaceted multinucleated giant cells in oral squamous cell carcinoma.
    Oral Oncol. 2021;121:105400.
    PubMed    


  435. HARING CT, Brummel C, Bhambhani C, Jewell B, et al
    Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation.
    Oral Oncol. 2021;121:105332.
    PubMed    


    September 2021
  436. CURY SS, Miranda PM, Marchi FA, Canto LMD, et al
    Germline variants in DNA repair genes are associated with young-onset head and neck cancer.
    Oral Oncol. 2021;122:105545.
    PubMed     Abstract available


  437. WANG BC
    Adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Finding the suitable population.
    Oral Oncol. 2021 Sep 28:105544. doi: 10.1016/j.oraloncology.2021.105544.
    PubMed    


  438. SARODE SC, Sarode GS, Sengupta N, Ghone U, et al
    Tobacco induced epithelial dysplasia at minor salivary gland excretory duct and oral cancer.
    Oral Oncol. 2021;122:105525.
    PubMed    


  439. TJOA T, Rathi VK, Goyal N, Yarlagadda BB, et al
    Pneumonia, urinary tract infection, bacteremia, and Clostridioides difficile infection following major head and neck free and pedicled flap surgeries.
    Oral Oncol. 2021;122:105541.
    PubMed     Abstract available


  440. MENON N, Patil V, Noronha V, Joshi A, et al
    Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone - Additional data from a phase 3 trial.
    Oral Oncol. 2021;122:105517.
    PubMed     Abstract available


  441. ZHU MY, Sun XS, Guo SS, Chen QY, et al
    Do all patients with locoregionally advanced nasopharyngeal carcinoma benefit from the maintenance chemotherapy using S-1/capecitabine?
    Oral Oncol. 2021;122:105539.
    PubMed     Abstract available


  442. ZHOU X, Xu T, Yang Y, Xing X, et al
    Survival impact of increasing time to IMRT initiation following induction chemotherapy in nasopharyngeal carcinoma: A propensity score-matched analysis.
    Oral Oncol. 2021;122:105506.
    PubMed     Abstract available


  443. KIONG KL, Bell D, Yao CM, Ferrarotto R, et al
    Multifocal regression and pathologic response predicts recurrence after neoadjuvant chemotherapy in head and neck squamous cell carcinoma.
    Oral Oncol. 2021;122:105520.
    PubMed     Abstract available


  444. AJAZ S, Muneer R, Siddiqa A, Ali Memon M, et al
    Association of specific single nucleotide variants (SNVs) in the promoter and 3'-Untranslated region of Vascular Endothelial growth factor (VEGF) gene with risk and higher tumour grade of head and neck cancers.
    Oral Oncol. 2021;122:105519.
    PubMed     Abstract available


  445. TSAI TY, Chou YC, Lu YA, Kang CJ, et al
    The prognostic value of radiologic extranodal extension in nasopharyngeal carcinoma: Systematic review and meta-analysis.
    Oral Oncol. 2021;122:105518.
    PubMed     Abstract available


  446. IDA S, Takahashi H, Kawabata-Iwakawa R, Mito I, et al
    Tissue-resident memory T cells correlate with the inflammatory tumor microenvironment and improved prognosis in head and neck squamous cell carcinoma.
    Oral Oncol. 2021;122:105508.
    PubMed     Abstract available


  447. SAKTHIVEL P, Malik A, Panda S, Dhiwakar M, et al
    8 "S" of obturators in Head and Neck Cancer Rehabilitation during COVID-19 pandemic.
    Oral Oncol. 2021 Sep 8:105523. doi: 10.1016/j.oraloncology.2021.105523.
    PubMed    


  448. MILLIET F, Bozec A, Schiappa R, Viotti J, et al
    Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric study.
    Oral Oncol. 2021;122:105503.
    PubMed     Abstract available


  449. VAN HINTE G, Sancak T, Weijs WLJ, Merkx MAW, et al
    Effect of elective neck dissection versus sentinel lymph node biopsy on shoulder morbidity and health-related quality of life in patients with oral cavity cancer: A longitudinal comparative cohort study.
    Oral Oncol. 2021;122:105510.
    PubMed     Abstract available


  450. D'SOUZA ZI, Desai RS, Shirsat PM, Bansal S, et al
    Comment on "Suture line recurrence and oral squamous cell carcinoma: A viewpoint" by Sarode et al (October 2020).
    Oral Oncol. 2021;120:105297.
    PubMed    


  451. CHIDAMBARANATHAN N, Thiagarajan S
    Is it time to look beyond just the depth of invasion to decide the management of neck in early oral squamous cell carcinoma?
    Oral Oncol. 2021;120:105291.
    PubMed    


  452. MEROLLA F, Ilardi G, Di Spigna G, Russo D, et al
    Detection of CAF-1/p60 in peripheral blood as a potential biomarker of HNSCC tumors.
    Oral Oncol. 2021;120:105367.
    PubMed     Abstract available


  453. HERREROS-POMARES A, Llorens C, Soriano B, Zhang F, et al
    Oral microbiome in Proliferative Verrucous Leukoplakia exhibits loss of diversity and enrichment of pathogens.
    Oral Oncol. 2021;120:105404.
    PubMed     Abstract available


  454. LI Z, Zhang L, Liu FY, Li P, et al
    MKP-1 is required to limit myeloid-cell mediated oral squamous cell carcinoma progression and regional extension.
    Oral Oncol. 2021;120:105401.
    PubMed     Abstract available


  455. GUDI S, O'Sullivan B, Hosni A, Su J, et al
    Outcome and treatment toxicity in east-indian versus white-canadian patients with oral cavity cancer following postoperative (chemo-)radiotherapy delivered under similar multidisciplinary care: A propensity-matched cohort study.
    Oral Oncol. 2021;120:105419.
    PubMed     Abstract available


  456. CHEN CM, Chu TH, Chou CC, Chien CY, et al
    Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis.
    Oral Oncol. 2021;120:105402.
    PubMed     Abstract available


  457. SHAH S, Mahajan A, Thiagarajan S, Chidambaranathan N, et al
    Importance and implications of neurovascular bundle involvement and other MRI findings of oral tongue squamous cell carcinoma (OTSCC) on prognosis.
    Oral Oncol. 2021;120:105403.
    PubMed     Abstract available


  458. TAN LC, Yu PC, Wang J, Zhou XY, et al
    BCOR-CCNB3 rearranged sarcoma arising in neck misdiagnosed as thyroid cancer: A case report.
    Oral Oncol. 2021;120:105290.
    PubMed     Abstract available


  459. FUJIMI A, Nagamachi Y, Yamauchi N, Nishisato T, et al
    Eribulin in combination with HER2-targeted antibodies for successful treatment of metastatic salivary duct carcinoma: A report of two cases.
    Oral Oncol. 2021;120:105287.
    PubMed    


  460. DE LIMA-SOUZA RA, Scarini JF, Egal ESA, Crescencio LR, et al
    Secretory carcinoma ex pleomorphic adenoma of the submandibular gland: An immunohistochemical study.
    Oral Oncol. 2021;120:105262.
    PubMed     Abstract available


    August 2021
  461. WRIGHT CM, Lee DY, Shimunov D, Carmona R, et al
    Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery.
    Oral Oncol. 2021;121:105509.
    PubMed     Abstract available


  462. VERDONCK-DE LEEUW IM, Melissant H, Lissenberg-Witte BI, Baatenburg de Jong RJ, et al
    Associations between testosterone and patient reported sexual outcomes among male and female head and neck cancer patients before and six months after treatment: A pilot study.
    Oral Oncol. 2021;121:105505.
    PubMed     Abstract available


  463. SCHAIK JEV, Halmos GB, Witjes MJH, Plaat BEC, et al
    An overview of the current clinical status of optical imaging in head and neck cancer with a focus on Narrow Band imaging and fluorescence optical imaging.
    Oral Oncol. 2021;121:105504.
    PubMed     Abstract available


  464. MYATRA SN, Gupta S, D'Cruz AK, Rajanala V, et al
    Identification of patients for a delayed extubation strategy versus elective tracheostomy for postoperative airway management in major oral cancer surgery: A prospective observational study in seven hundred and twenty patients.
    Oral Oncol. 2021;121:105502.
    PubMed     Abstract available


  465. MIN Y, Xiang K, Feng Y, Chen H, et al
    Development and validation of a population-based model for predicting the regional lymph node metastasis in adolescent differentiated thyroid carcinoma.
    Oral Oncol. 2021;121:105507.
    PubMed     Abstract available


  466. YANG Q, Xia L, Lin M, Zhang MX, et al
    The impact of induction chemotherapy on long-term quality of life in patients with locoregionally advanced nasopharyngeal carcinoma: Outcomes from a randomised phase 3 trial.
    Oral Oncol. 2021;121:105494.
    PubMed     Abstract available


  467. HOCHFELDER CG, Mehta V, Kabarriti R, McGinn AP, et al
    Survival analysis of patients with advanced hypopharyngeal cancer comparing patients who received primary surgery to those who received chemoradiation: An analysis of the NCDB.
    Oral Oncol. 2021;121:105470.
    PubMed     Abstract available


  468. BUENO DE OLIVEIRA T, Camila Braun A, Ribaldo Nicolau U, Ali Abdallah E, et al
    Prognostic impact and potential predictive role of baseline circulating tumor cells in locally advanced head and neck squamous cell carcinoma.
    Oral Oncol. 2021;121:105480.
    PubMed     Abstract available


  469. NAGPAL P, Pruthi DS, Pandey M, Yadav A, et al
    Impact of sarcopenia in locally advanced head and neck cancer treated with chemoradiation: An Indian tertiary care hospital experience.
    Oral Oncol. 2021;121:105483.
    PubMed     Abstract available


  470. JAWERT F, Nyman J, Olsson E, Adok C, et al
    Regular clinical follow-up of oral potentially malignant disorders results in improved survival for patients who develop oral cancer.
    Oral Oncol. 2021;121:105469.
    PubMed     Abstract available


  471. OHKOSHI A, Ishii R, Wakamori S, Nakayama Y, et al
    Serum selenium predicts achievement of full-dose cisplatin in concurrent chemoradiotherapy for locally advanced head and neck squamous cell carcinoma: A prospective, observational study.
    Oral Oncol. 2021;121:105475.
    PubMed     Abstract available


  472. ENGEL MSD, van der Lans RJL, Jansen JC, Leemans CR, et al
    Management and outcome of middle ear adenomatous neuroendocrine tumours: A systematic review.
    Oral Oncol. 2021;121:105465.
    PubMed     Abstract available


  473. SAKTHIVEL P, Subramanian P, Pulimala S, Panda S, et al
    A call for the universal acceptance of the modified Milan system for reporting salivary gland cytopathology.
    Oral Oncol. 2021;119:105255.
    PubMed    


  474. MCDOWELL L, Corry J
    Regarding "Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: An international practice pattern survey" - Intra- and inter-specialty variability and the underutilisation o
    Oral Oncol. 2021;119:105248.
    PubMed    


  475. TRETIAKOW D, Przewozny T, Skorek A, Mikaszewski B, et al
    Regarding to "Minimaly invasive benign parotid surgery in selected patients: An adaptation example to compensate for COVID19 backlog or new era?"
    Oral Oncol. 2021;119:105227.
    PubMed    


  476. KANG CJ, Tsai CY, Lee LY, Lin CY, et al
    Prognostic stratification of patients with AJCC 2018 pStage IVB oral cavity cancer: Should pT4b and pN3 disease be reclassified?
    Oral Oncol. 2021;119:105371.
    PubMed     Abstract available


  477. PANG Y, Sun L, Liu H, Ma J, et al
    Differential diagnosis and treatment of salivary secretory carcinoma and acinic cell carcinoma.
    Oral Oncol. 2021;119:105370.
    PubMed     Abstract available


  478. HARRIS JA, Hunter WP, Ji YD, Hanna GJ, et al
    Effects of racial residential segregation on oral squamous cell carcinoma prognosis and survival.
    Oral Oncol. 2021;119:105364.
    PubMed     Abstract available


  479. FARAH CS, Fox S, Shearston K, Newman L, et al
    Lichenoid dysplasia is not a distinct pathological entity.
    Oral Oncol. 2021;119:105362.
    PubMed     Abstract available


  480. CHOI N, Kim Z, Song BH, Park W, et al
    Prediction of risk factors for pharyngo-cutaneous fistula after total laryngectomy using artificial intelligence.
    Oral Oncol. 2021;119:105357.
    PubMed     Abstract available


  481. SUBRAMANIAM N, Palme CE, Low TH
    Combined approach for malignant tumours of the deep lobe of the parotid involving the stylomandibular tunnel and parapharyngeal space.
    Oral Oncol. 2021;119:105283.
    PubMed    


  482. MARANZANO M, D'Ascanio L, Ricci G, Omer H, et al
    Misinterpretation of head and neck masses can delay the correct diagnosis. A two-step demolitive-reconstruction surgery for saving patient's life.
    Oral Oncol. 2021;119:105197.
    PubMed     Abstract available


  483. FIACCHINI G, Benettini G, Trico D, Torregrossa L, et al
    Human papillomavirus-related head and neck adenosquamous carcinoma: A systematic review and individual patient data meta-analysis.
    Oral Oncol. 2021;119:105252.
    PubMed     Abstract available


  484. SINGH N, Das S, Mehta S
    Oral tumour causing airway obstruction with stridor: Situation guided team management.
    Oral Oncol. 2021;119:105247.
    PubMed    


  485. MUNNANGI A, Kadapathri A, Pillai V, Shetty V, et al
    Should radiological staging of advanced buccal mucosa cancer preclude curative intent treatment? A prospective evaluation.
    Oral Oncol. 2021;119:105246.
    PubMed    


    July 2021
  486. MAO L, Xiao Y, Yang QC, Yang SC, et al
    TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells.
    Oral Oncol. 2021;121:105472.
    PubMed     Abstract available


  487. NIEUWENHUIS ER, Kolenaar B, van Bemmel AJM, Hof JJ, et al
    A complete magnetic sentinel lymph node biopsy procedure in oral cancer patients: A pilot study.
    Oral Oncol. 2021;121:105464.
    PubMed     Abstract available


  488. MATSUDA Y, Okui T, Karino M, Aoi N, et al
    Postoperative oral dysfunction following oral cancer resection and reconstruction: A preliminary cross-sectional study.
    Oral Oncol. 2021;121:105468.
    PubMed     Abstract available


  489. NAUTA IH, Klausch T, van de Ven PM, Hoebers FJP, et al
    The important role of cisplatin in the treatment of HPV-positive oropharyngeal cancer assessed by real-world data analysis.
    Oral Oncol. 2021;121:105454.
    PubMed     Abstract available


  490. DRAKE V, Bigelow E, Fakhry C, Windon M, et al
    Biologic and behavioral associations of estrogen receptor alpha positivity in head and neck squamous cell carcinoma.
    Oral Oncol. 2021;121:105461.
    PubMed     Abstract available


  491. KIM C, Martinez E, Kulich M, Swanson MS, et al
    Surgeon practice patterns in transoral robotic surgery for HPV-related oropharyngeal cancer.
    Oral Oncol. 2021;121:105460.
    PubMed     Abstract available


  492. XU Y, Chen M, Guo Q, Peng H, et al
    Percutaneous endoscopic gastrostomy can improve survival outcomes in patients with N3 nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy.
    Oral Oncol. 2021;121:105435.
    PubMed     Abstract available


  493. ALMANGUSH A, Alabi RO, Makitie AA, Leivo I, et al
    Machine learning in head and neck cancer: Importance of a web-based prognostic tool for improved decision making.
    Oral Oncol. 2021 Jul 12:105452. doi: 10.1016/j.oraloncology.2021.105452.
    PubMed    


  494. KOUKETSU A, Miyashita H, Kojima I, Sakamoto M, et al
    Comparison of different diagnostic imaging techniques for the detection of bone invasion in oral cancers.
    Oral Oncol. 2021;120:105453.
    PubMed     Abstract available


  495. MERCHANT YP, Kudpaje A, Rao VUS
    Extent of neck dissection in the N+ neck: Adjudicating a Conundrum!
    Oral Oncol. 2021 Jul 11:105441. doi: 10.1016/j.oraloncology.2021.105441.
    PubMed    


  496. IQBAL MS, Kovarik J, Patil R, Kelly CG, et al
    Are taxanes more effective than 5FU in combination chemotherapy for recurrent and metastatic head and neck cancer?
    Oral Oncol. 2021 Jul 9:105455. doi: 10.1016/j.oraloncology.2021.105455.
    PubMed    


  497. IMADUDDIN M, Sultania M, Vigneshwaran B, Muduly DK, et al
    Psychosocial Factors in an Oral Cancer Survivor Leading to Delay in Seeking Help.
    Oral Oncol. 2021 Jul 5:105438. doi: 10.1016/j.oraloncology.2021.105438.
    PubMed    


  498. WILKIE MD, Lancaster J, Roland NJ, Jones TM, et al
    Elective management of regional nodal basins in cutaneous squamous cell carcinoma of the head and neck: Controversies and contemporary perspectives.
    Oral Oncol. 2021;120:105432.
    PubMed     Abstract available


  499. KIM SY, Beer M, Tshering Vogel DW
    Imaging in head and neck cancers: Update for non-radiologist.
    Oral Oncol. 2021;120:105434.
    PubMed     Abstract available


  500. FARLOW JL, Brenner JC, Lei YL, Chinn SB, et al
    Immune deserts in head and neck squamous cell carcinoma: A review of challenges and opportunities for modulating the tumor immune microenvironment.
    Oral Oncol. 2021;120:105420.
    PubMed     Abstract available


  501. STABENAU KA, Akakpo KE, Richmon JD, McMullen C, et al
    Postoperative wound infections in head and neck surgery: The current state of antiseptic and antibiotic practices.
    Oral Oncol. 2021;118:105361.
    PubMed    


  502. DA COSTA REAR, da Silva Junior RG, Magalhaes LAN, Mendes JR, et al
    Locally advanced lymphoepithelial carcinoma of the larynx/hypopharynx: A case report.
    Oral Oncol. 2021;118:105373.
    PubMed     Abstract available


  503. SHARMA D, Rimal J, Kumar Maharjan I, Shrestha A, et al
    Evaluation of oral potentially malignant disorders with autoflorescence, reflectance spectroscopy and vital staining and their correlation with histopathology - Hospital based prospective study.
    Oral Oncol. 2021;118:105312.
    PubMed     Abstract available


  504. PANTA P, Dhopathi SR, Gilligan G, Seshadri M, et al
    Invasive oral squamous cell carcinoma induced by concurrent smokeless tobacco and creamy snuff use: A case report.
    Oral Oncol. 2021;118:105354.
    PubMed     Abstract available


  505. TSAI CY, Lee SR, Lee LY, Hsueh C, et al
    Clinical outcomes of Taiwanese patients with resected squamous cell carcinoma of the upper and lower gum.
    Oral Oncol. 2021;118:105334.
    PubMed     Abstract available


  506. BARRETT TF, Mazul AL, Stepan KO, Wood CB, et al
    The role of age in treatment decisions for oral cavity squamous cell carcinoma: Analysis of the National Cancer Database.
    Oral Oncol. 2021;118:105330.
    PubMed     Abstract available


  507. DE LIMA-SOUZA RA, Leonel ACLDS, de Almeida OP, de Castro JFL, et al
    Salivary gland cystadenocarcinoma: Rare neoplasm in buccal mucosa.
    Oral Oncol. 2021;118:105314.
    PubMed     Abstract available


  508. DESAI RS, Shirsat PM, Bansal S, Prasad P, et al
    Oral field cancerization: A critical appraisal.
    Oral Oncol. 2021;118:105304.
    PubMed    


  509. JAKHETIYA A, Kaul P, Pandey A, Patel T, et al
    Distribution and determinants of submandibular gland involvement in oral cavity squamous cell carcinoma.
    Oral Oncol. 2021;118:105316.
    PubMed     Abstract available


  510. TURNER MT, Stokes WA, Stokes CM, Hassid S, et al
    Airway and bleeding complications of transoral robotic supraglottic laryngectomy (TORS-SGL): A systematic review and meta-analysis.
    Oral Oncol. 2021;118:105301.
    PubMed    


  511. MCDOWELL L, Gough K, King M, Corry J, et al
    Patient-reported quality of life and symptom burden measures in human papillomavirus associated oropharyngeal cancer - A review of the literature and PRO methodology.
    Oral Oncol. 2021;118:105309.
    PubMed     Abstract available


  512. DHEERAJ K, Kumar R, Pinnaka LB
    6 "I" for endoscopic surgical management of early glottic squamous cell carcinomas.
    Oral Oncol. 2021;118:105308.
    PubMed    


    June 2021
  513. PATEL KB, Mroz EA, Faquin WC, Rocco JW, et al
    A combination of intra-tumor genetic heterogeneity, estrogen receptor alpha and human papillomavirus status predicts outcomes in head and neck squamous cell carcinoma following chemoradiotherapy.
    Oral Oncol. 2021;120:105421.
    PubMed     Abstract available


  514. RIBEIRO IP, Lopes T, Pedro N, Barroso L, et al
    Should sitting time be a treatment target in head and neck cancer patients receiving curative treatment?
    Oral Oncol. 2021 Jun 26:105418. doi: 10.1016/j.oraloncology.2021.105418.
    PubMed    


  515. DAHLSTROM KR, Anderson KS, Guo M, Kwon MC, et al
    Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men: Initial report from the HOUSTON clinical trial.
    Oral Oncol. 2021;120:105397.
    PubMed     Abstract available


  516. YANG J, Wan SQ, Huang L, Zhong WJ, et al
    Analysis of hospitalization costs and length of stay for oral cancer patients undergoing surgery: Evidence from Hunan, China.
    Oral Oncol. 2021;119:105363.
    PubMed     Abstract available


  517. AMBRE S, Sultania M, Biswal S, Mitra S, et al
    Poorly differentiated "insular" thyroid carcinoma with solitary vascular mandibular metastasis - A rare histology and management.
    Oral Oncol. 2021 Jun 24:105416. doi: 10.1016/j.oraloncology.2021.105416.
    PubMed    


  518. ZHU MY, Wu HJ, Miao JJ, Di MP, et al
    Radiation-induced hypothyroidism in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy with or without chemotherapy: Development of a nomogram based on the equivalent dose.
    Oral Oncol. 2021;120:105378.
    PubMed     Abstract available


  519. LENZE NR, Farquhar DR, Sheth S, Zevallos JP, et al
    Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinoma.
    Oral Oncol. 2021;119:105377.
    PubMed     Abstract available


  520. LIEN MY, Wang TH, Hsieh CY, Tsai MH, et al
    Both combined or sequential use with immune checkpoint inhibitors on cetuximab-treated patients with recurrent or metastatic head and neck squamous cell carcinoma improve the overall survival.
    Oral Oncol. 2021;119:105380.
    PubMed     Abstract available


  521. KAVARTHAPU A, Gurumoorthy K
    Linking chronic periodontitis and oral cancer: A review.
    Oral Oncol. 2021 Jun 14:105375. doi: 10.1016/j.oraloncology.2021.105375.
    PubMed     Abstract available


  522. MA C, Sheng S, Shen Y, Gao W, et al
    A comparative study on using superior thyroid artery perforator flaps versus traditional sternocleidomastoid myocutaneous flaps for reconstructions after oral cancer ablation: "New tricks for old dogs"?
    Oral Oncol. 2021 Jun 11:105374. doi: 10.1016/j.oraloncology.2021.105374.
    PubMed     Abstract available


  523. BRAS L, de Vries J, Festen S, Steenbakkers RJHM, et al
    Frailty and restrictions in geriatric domains are associated with surgical complications but not with radiation-induced acute toxicity in head and neck cancer patients: A prospective study.
    Oral Oncol. 2021;118:105329.
    PubMed     Abstract available


  524. KARABAJAKIAN A, Bouaoud J, Michon L, Kamal M, et al
    Longitudinal assessment of PD-L1 expression and gene expression profiles in patients with head and neck cancer reveals temporal heterogeneity.
    Oral Oncol. 2021;119:105368.
    PubMed     Abstract available


  525. XU J, Wang R, Wang T, Wang T, et al
    Targeted DNA profiling and the prevalence of NTRK aberrations in Chinese patients with head and neck cancer.
    Oral Oncol. 2021;119:105369.
    PubMed     Abstract available


  526. ALVES LDB, de Melo AC, de Lima Araujo LH, Thiago LS, et al
    Secretory carcinoma of salivary glands at the National Cancer Institute: A 20-year retrospective clinical, pathological, immunohistochemical and molecular study.
    Oral Oncol. 2021;117:105198.
    PubMed     Abstract available


  527. VARGHESE BT, Divya GM, Janardhan D, Thomas S, et al
    Is there a role for HRCT in head and neck surgical oncology work up during the COVID pandemic?
    Oral Oncol. 2021;117:105194.
    PubMed    


  528. JIANG WN, Olson R
    Transoral surgery may be less cost effective than radiotherapy: In response to: Comparative cost analysis between definitive radiotherapy and transoral surgery for oropharyngeal squamous cell carcinoma: A SEER-medicare analysis.
    Oral Oncol. 2021;117:105178.
    PubMed    


  529. PARIKH AS, Kang SY
    Variation in elective treatment of the contralateral neck in oropharyngeal cancer.
    Oral Oncol. 2021;117:105186.
    PubMed    


  530. SARODE GS, Sarode SC, Sengupta N, Sharma NK, et al
    Readdressing dysplasia at surgical margins as predictive biomarker of malignant transformation.
    Oral Oncol. 2021;117:105181.
    PubMed     Abstract available


  531. COMBES JD, Voisin N, Perie S, Malard O, et al
    History of tonsillectomy and risk of oropharyngeal cancer.
    Oral Oncol. 2021;117:105302.
    PubMed     Abstract available


  532. PATEL MR, Ottenstein L, Ryan M, Farrell A, et al
    TORS elective lingual tonsillectomy has less acute morbidity than therapeutic base of tongue TORS.
    Oral Oncol. 2021;117:105294.
    PubMed     Abstract available


  533. HEFT NEAL ME, Gensterblum-Miller E, Bhangale AD, Kulkarni A, et al
    Integrative sequencing discovers an ATF1-motif enriched molecular signature that differentiates hyalinizing clear cell carcinoma from mucoepidemoid carcinoma.
    Oral Oncol. 2021;117:105270.
    PubMed     Abstract available


  534. BURASSAKARN A, Srisathaporn S, Pientong C, Wongjampa W, et al
    Exosomes-carrying Epstein-Barr virus-encoded small RNA-1 induces indoleamine 2, 3-dioxygenase expression in tumor-infiltrating macrophages of oral squamous-cell carcinomas and suppresses T-cell activity by activating RIG-I/IL-6/TNF-alpha pathway.
    Oral Oncol. 2021;117:105279.
    PubMed     Abstract available


    May 2021
  535. TECKIE S, Wotman M, Marziliano A, Orner D, et al
    Patterns of alcohol use among early head and neck cancer survivors: A cross-sectional survey study using the alcohol use disorders identification test (AUDIT).
    Oral Oncol. 2021;119:105328.
    PubMed     Abstract available


  536. DE FELICE F, Lei M, Oakley R, Lyons A, et al
    Risk stratified follow up for head and neck cancer patients - An evidence based proposal.
    Oral Oncol. 2021;119:105365.
    PubMed     Abstract available


  537. LIN MC, Leu YS, Chiang CJ, Ko JY, et al
    Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis.
    Oral Oncol. 2021;119:105358.
    PubMed     Abstract available


  538. PENG Y, Xiao L, Rong H, Ou Z, et al
    Single-cell profiling of tumor-infiltrating TCF1/TCF7(+) T cells reveals a T lymphocyte subset associated with tertiary lymphoid structures/organs and a superior prognosis in oral cancer.
    Oral Oncol. 2021;119:105348.
    PubMed     Abstract available


  539. COSTANTINO A, De Virgilio A, Spriano G
    Is the current oropharyngeal cancer T classification adequate in the era of HPV and transoral robotic surgery?
    Oral Oncol. 2021 May 25:105359. doi: 10.1016/j.oraloncology.2021.105359.
    PubMed    


  540. DESIDERI I, Becherini C, Belgioia L, Merlotti A, et al
    Palliative radiotherapy in older adults with head and neck squamous cell carcinoma: A systematic review.
    Oral Oncol. 2021;119:105355.
    PubMed     Abstract available


  541. BERZENJI D, Sewnaik A, Keereweer S, Monserez DA, et al
    Dissemination patterns and chronology of distant metastasis affect survival of patients with head and neck squamous cell carcinoma.
    Oral Oncol. 2021;119:105356.
    PubMed     Abstract available


  542. SCHOONBEEK RC, Bult FFS, Plaat BEC, Witjes MJH, et al
    Incidental findings during the diagnostic work-up in the head and neck cancer pathway: Effects on treatment delay and survival.
    Oral Oncol. 2021;118:105350.
    PubMed     Abstract available


  543. CHEN X, Li Y, Li X, Cao X, et al
    An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features.
    Oral Oncol. 2021;118:105335.
    PubMed     Abstract available


  544. PATTERSON JM, Lu L, Watson LJ, Harding S, et al
    Trends in, and predictors of, swallowing and social eating outcomes in head and neck cancer survivors: A longitudinal analysis of head and neck 5000.
    Oral Oncol. 2021;118:105344.
    PubMed     Abstract available


  545. AL-QURAYSHI Z, Randolph GW, Kandil E
    Cost-effectiveness of computed tomography nodal scan in patients with papillary thyroid carcinoma.
    Oral Oncol. 2021;118:105326.
    PubMed     Abstract available


  546. VENTURA TMO, Santos PSS, Ribeiro NR, de Lima Leite A, et al
    Is there difference in the comparative and quantitative salivary proteome between stimulated and unstimulated saliva in head and neck cancer patients treated by radiotherapy?
    Oral Oncol. 2021 May 10:105315. doi: 10.1016/j.oraloncology.2021.105315.
    PubMed     Abstract available


  547. ZHOU L
    Concerns about human papillomavirus-associated oropharyngeal cancer detection methods.
    Oral Oncol. 2021;116:105143.
    PubMed    


  548. THADURI A, Bansal A, Anthony ML, Narayan ML, et al
    Brown tumor, parathyroid adenoma, and papillary thyroid cancer: A triple whammy.
    Oral Oncol. 2021;116:105159.
    PubMed    


  549. DOUMAS S, Koursoumi R, Dhanda J, Surwald C, et al
    Minimaly invasive benign parotid surgery in selected patients: An adaptation example to compensate for COVID19 backlog or new era?
    Oral Oncol. 2021;116:105170.
    PubMed    


  550. NGUYEN A, Nagasaka M
    Forget me not - Incorporating standard chemotherapy in an exciting era of clinical trials.
    Oral Oncol. 2021;116:105160.
    PubMed     Abstract available


  551. RODRIGUES-FERNANDES CI, Arboleda LPA, Vargas PA, Lopes MA, et al
    Oral verrucous carcinoma manifesting as proliferative verrucous leukoplakia.
    Oral Oncol. 2021;116:105144.
    PubMed     Abstract available


  552. HAIST C, Schulte E, Bartels N, Bister A, et al
    CD44v6-targeted CAR T-cells specifically eliminate CD44 isoform 6 expressing head/neck squamous cell carcinoma cells.
    Oral Oncol. 2021;116:105259.
    PubMed     Abstract available


  553. DE KONING KJ, Koppes SA, de Bree R, Dankbaar JW, et al
    Feasibility study of ultrasound-guided resection of tongue cancer with immediate specimen examination to improve margin control - Comparison with conventional treatment.
    Oral Oncol. 2021;116:105249.
    PubMed     Abstract available


  554. SAKTHIVEL P, Raveendran S, Panda S, Singh CA, et al
    Oral potential malignant disorders - A long list not to be forgotten.
    Oral Oncol. 2021;116:105244.
    PubMed    


  555. HERREROS-POMARES A, Llorens C, Soriano B, Bagan L, et al
    Differentially methylated genes in proliferative verrucous leukoplakia reveal potential malignant biomarkers for oral squamous cell carcinoma.
    Oral Oncol. 2021;116:105191.
    PubMed     Abstract available


  556. LI R, Wang Q, Yan L, Zhu Y, et al
    Radiotherapy versus partial laryngectomy in the management of early glottic cancer with anterior commissure involvement: A propensity score matched study with 256 patients.
    Oral Oncol. 2021;116:105230.
    PubMed     Abstract available


  557. NEWMAN M, Dziegielewski PT, Nguyen NTA, Seikaly HS, et al
    Relationship of depth of invasion to survival outcomes and patterns of recurrence for T3 oral tongue squamous cell carcinoma.
    Oral Oncol. 2021;116:105195.
    PubMed     Abstract available


  558. OH LJ, Asher R, Veness M, Smee R, et al
    Effect of age and gender in non-smokers with oral squamous cell carcinoma: Multi-institutional study.
    Oral Oncol. 2021;116:105210.
    PubMed     Abstract available


  559. BAREM RABENHORST SH, Lima Verde Osterne R, Weege Nonaka CF, Montezuma Sales Rodrigues A, et al
    Detection of deletions in 1q25, 1p36 and 1pTEL and chromosome 17 aneuploidy in oral epithelial dysplasia and oral squamous cell carcinoma by fluorescence in situ hybridization (FISH).
    Oral Oncol. 2021;116:105221.
    PubMed     Abstract available


    April 2021
  560. DA SILVA LEONEL ACL, Ribeiro ILA, de Souza MLM, Kaminagakura E, et al
    COVID-19, changes in smoking behaviour, and head and neck cancer: Current data and future perspectives.
    Oral Oncol. 2021 Apr 30:105327. doi: 10.1016/j.oraloncology.2021.105327.
    PubMed    


  561. ZONG J, Liu Y, Liang Q, Xu H, et al
    Administration of oral maintenance chemotherapy for 1 year following definitive chemoradiotherapy may improve the survival of patients with stage N3 nasopharyngeal carcinoma.
    Oral Oncol. 2021;118:105313.
    PubMed     Abstract available


  562. SINHA NK, Kohli PS, Nagarajan K, Gochhait D, et al
    A nomogram for predicting the risk of neck node metastasis in oral cavity carcinoma using acoustic radiation force impulse imaging (ARFI).
    Oral Oncol. 2021;118:105311.
    PubMed     Abstract available


  563. YVER CM, Shimunov D, Weinstein GS, Rajasekaran K, et al
    Oncologic and survival outcomes for resectable locally-advanced HPV-related oropharyngeal cancer treated with transoral robotic surgery.
    Oral Oncol. 2021;118:105307.
    PubMed     Abstract available


  564. LYNCH PT, Horani S, Lee R, Sumer BD, et al
    Effectiveness of physical activity interventions in improving objective and patient-reported outcomes in head and neck cancer survivors: A systematic review.
    Oral Oncol. 2021;117:105253.
    PubMed     Abstract available


  565. VALLINA C, Lopez-Pintor RM, Gonzalez-Serrano J, de Vicente JC, et al
    Genes involved in the epithelial-mesenchymal transition in oral cancer: A systematic review.
    Oral Oncol. 2021;117:105310.
    PubMed     Abstract available


  566. RAJASEKARAN K, Carey RM, Lin X, Seckar TD, et al
    The microbiome of HPV-positive tonsil squamous cell carcinoma and neck metastasis.
    Oral Oncol. 2021;117:105305.
    PubMed     Abstract available


  567. KREINBRINK PJ, Li J, Parajuli S, Wise-Draper TM, et al
    Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma.
    Oral Oncol. 2021;116:105245.
    PubMed     Abstract available


  568. DHAKAL R, Moeller BJ, Prabhu RS, Frenkel CH, et al
    Pattern of distant metastasis in oropharyngeal carcinoma - Do they differ by HPV status?
    Oral Oncol. 2021 Apr 18:105286. doi: 10.1016/j.oraloncology.2021.105286.
    PubMed    


  569. FANNY C, Sebastien L, Pascale G, Antoine N, et al
    Physician practice variation in head and neck cancer therapy: Results of a national survey.
    Oral Oncol. 2021;117:105293.
    PubMed     Abstract available


  570. MOUTAFI M, Economopoulou P, Rimm D, Psyrri A, et al
    PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical data.
    Oral Oncol. 2021;117:105292.
    PubMed     Abstract available


  571. XIANG ZF, Hu DF, Xiong HC, Li MY, et al
    Benefit of chemotherapy in stage III nasopharyngeal carcinoma: Analysis of the surveillance, epidemiology, and end results database.
    Oral Oncol. 2021;117:105284.
    PubMed     Abstract available


  572. KUMAR R, Dheeraj K
    Do ipsilateral lateralized squamous cell carcinomas of oral tongue with a depth of invasion (DOI) greater than 10 mm warrant a bilateral neck dissection to prevent future regional recurrences on contralateral side? A continuing conundrum.
    Oral Oncol. 2021 Apr 7:105285. doi: 10.1016/j.oraloncology.2021.105285.
    PubMed    


  573. SCHREIBER A, Mattavelli D, Accorona R, Rampinelli V, et al
    Endoscopic-assisted multi-portal compartmental resection of the masticatory space in oral cancer: Anatomical study and preliminary clinical experience.
    Oral Oncol. 2021;117:105269.
    PubMed     Abstract available


  574. RAUSO R, Chirico F, Federico F, Francesco Nicoletti G, et al
    Maxillo-facial reconstruction following cancer ablation during COVID-19 pandemic in southern Italy.
    Oral Oncol. 2021;115:105114.
    PubMed     Abstract available


  575. SAKTHIVEL P, Raveendran S, Panda S, Singh CA, et al
    Synchronous primary neoplasia in patients with p16 positive oropharyngeal carcinoma: Does the 2nd cancer really matters?
    Oral Oncol. 2021;115:105113.
    PubMed    


  576. PARAG-SHARMA K, Tasoulas J, Musicant AM, do Nascimento-Filho CHV, et al
    Synergistic efficacy of combined EGFR and HDAC inhibitors overcomes tolerance to EGFR monotherapy in salivary mucoepidermoid carcinoma.
    Oral Oncol. 2021;115:105166.
    PubMed     Abstract available


  577. LIU HY, Tam L, Woody NM, Caudell J, et al
    Failure rate in the untreated contralateral node negative neck of small lateralized oral cavity cancers: A multi-institutional collaborative study.
    Oral Oncol. 2021;115:105190.
    PubMed     Abstract available


  578. LORINI L, Ardighieri L, Bozzola A, Romani C, et al
    Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma.
    Oral Oncol. 2021;115:105213.
    PubMed     Abstract available


  579. PRICE JM, West CM, Mistry HB, Betts G, et al
    Improved survival prediction for oropharyngeal cancer beyond TNMv8.
    Oral Oncol. 2021;115:105140.
    PubMed     Abstract available


  580. TRETIAKOW D, Mollin E, Stodulski D
    Metastasis of the testicular germ cell tumors to the parotid gland.
    Oral Oncol. 2021;115:105132.
    PubMed    


  581. LOMBARDI N, Varoni EM, Moneghini L, Lodi G, et al
    Submucosal oral squamous cell carcinoma of the tongue.
    Oral Oncol. 2021;115:105121.
    PubMed    


  582. GANCI F, Allegretti M, Manciocco V, Fiorentino F, et al
    Two distinct TP53 mutations in HNSCC primary tumor: Only one circulates in the blood.
    Oral Oncol. 2021;115:105096.
    PubMed    


  583. HUANG NS, Cao YM, Lu ZW, Guan Q, et al
    Mammary analog secretory carcinoma of the thyroid gland: A rare cancer harboring TRK fusion.
    Oral Oncol. 2021;115:105092.
    PubMed     Abstract available


    March 2021
  584. DESAI RS, Shirsat PM, Bansal S, Prasad P, et al
    Comment on "Malignant transformation evidences of Oral Lichen Planus: When the time is of the essence" by Zotti F et al (May 2020).
    Oral Oncol. 2021;114:105080.
    PubMed    


  585. DE ALMEIDA JR, Seungyeon Kim V, O'Sullivan B, Goldstein DP, et al
    Comparing unilateral vs. bilateral neck management in lateralized oropharyngeal cancer between surgical and radiation oncologists: An international practice pattern survey.
    Oral Oncol. 2021;114:105165.
    PubMed     Abstract available


  586. FERRARI M, Migliorati S, Tomasoni M, Crisafulli V, et al
    Sinonasal cancer encroaching the orbit: Ablation or preservation?
    Oral Oncol. 2021;114:105185.
    PubMed     Abstract available


  587. YANG K, Ahn YC, Nam H, Hong SD, et al
    Clinical features of post-radiation nasopharyngeal necrosis and their outcomes following surgical intervention in nasopharyngeal cancer patients.
    Oral Oncol. 2021;114:105180.
    PubMed     Abstract available


  588. HENG Y, Zhang D, Zhou L, Zhang M, et al
    Assessment and treatment strategies for occult contralateral lymph node metastasis in hypopharyngeal squamous cell carcinoma patients with ipsilateral node-positive necks.
    Oral Oncol. 2021;114:105183.
    PubMed     Abstract available


  589. BENOIT C, Orbach D, Cyrille S, Belhous K, et al
    Head and neck tumors in children and adolescents: Impact of a multidisciplinary tumor board.
    Oral Oncol. 2021;114:105145.
    PubMed     Abstract available


  590. CUI J, Wang D, Nie D, Liu W, et al
    Difference in tumor mutation burden between squamous cell carcinoma in the oral cavity and larynx.
    Oral Oncol. 2021;114:105142.
    PubMed     Abstract available


  591. OPPELT P, Ley JC, Worden F, Palka K, et al
    Palbociclib and cetuximab in cetuximab-resistant human papillomavirus-related oropharynx squamous-cell carcinoma: A multicenter phase 2 trial.
    Oral Oncol. 2021;114:105164.
    PubMed     Abstract available


  592. LIN NC, Su IH, Hsu JT, Chang YJ, et al
    Comparison of different lymph node staging systems in patients with positive lymph nodes in oral squamous cell carcinoma.
    Oral Oncol. 2021;114:105146.
    PubMed     Abstract available


  593. LEE NCJ, Eskander A, Miccio JA, Park HS, et al
    Evaluation of head and neck soft tissue sarcoma 8th edition pathologic staging system and proposal of a novel stage grouping system.
    Oral Oncol. 2021;114:105137.
    PubMed     Abstract available


  594. GOOSMANN M, Chang S, Craig J
    Treating sinonasal crusting and infection after palatal and sinonasal cancer resection with topical antibiotic irrigations.
    Oral Oncol. 2021;114:105077.
    PubMed    


  595. ERKUL E, Yilmaz I
    TERT promoter mutation in patients with second primary of tongue squamous cell carcinoma.
    Oral Oncol. 2021;114:105089.
    PubMed     Abstract available


  596. GOMES N, Huynh A, Borel C, Guenounou S, et al
    Oral acute graft versus host disease after donor lymphocyte infusions: Clinicopathological characterization in a monocenter cohort.
    Oral Oncol. 2021;114:105082.
    PubMed     Abstract available


  597. LEITE AK, Kulcsar MAV, Matsuura D, Matos LL, et al
    Amelanotic melanoma presenting as a tongue tumor.
    Oral Oncol. 2021;114:105075.
    PubMed    


  598. SINGHAVI HR, Khare N, Singh A, Khandelwal A, et al
    Impact of pre-operative serum C-reactive protein and cell-free chromatin levels on tumor aggressiveness and survival outcome in oral cavity squamous cell carcinoma.
    Oral Oncol. 2021;114:105078.
    PubMed     Abstract available


  599. DHARA V, Kudva A, Chithra A, Rajan J, et al
    Reconstruction of buccal mucosa: A minimalist symbiotic approach with local flaps.
    Oral Oncol. 2021;114:105081.
    PubMed     Abstract available


    February 2021
  600. FREIHAT O, Toth Z, Pinter T, Kedves A, et al
    Pre-treatment PET/MRI based FDG and DWI imaging parameters for predicting HPV status and tumor response to chemoradiotherapy in primary oropharyngeal squamous cell carcinoma (OPSCC).
    Oral Oncol. 2021;116:105239.
    PubMed     Abstract available


  601. FADEN DL, O'Boyle CJ, Lin DT, Deschler DG, et al
    Prospective assessment of multiple HPV-positive oropharyngeal squamous cell carcinomas.
    Oral Oncol. 2021 Feb 15:105212. doi: 10.1016/j.oraloncology.2021.105212.
    PubMed    


  602. SENGUPTA N, Sarode GS, Sarode SC, Gadbail AR, et al
    Optimum surgical margins in squamous cell carcinoma of the oral tongue: Does shrinkage matters?
    Oral Oncol. 2021;113:105052.
    PubMed    


  603. GONZALEZ-MOLES MA, Warnakulasuriya S, Gonzalez-Ruiz I, Gonzalez-Ruiz L, et al
    Clinical interpretation of findings from a systematic review and a comprehensive meta-analysis on clinicopathological and prognostic characteristics of oral squamous cell carcinomas (OSCC) arising in patients with oral lichen planus (OLP): Author's re
    Oral Oncol. 2021;113:105036.
    PubMed    


  604. TRETIAKOW D, Stodulski D, Mikaszewski B
    Regarding the "Tumour spillage of the pleomorphic adenoma of the parotid gland: A proposal for intraoperative measures".
    Oral Oncol. 2021;113:105026.
    PubMed    


  605. LEE SJ, Kim YS, Kay CS, Kim M, et al
    The effect of adjuvant chemotherapy and early tumor regression on the outcome of nasopharyngeal cancer patients treated with concurrent chemoradiotherapy.
    Oral Oncol. 2021;113:105130.
    PubMed     Abstract available


  606. MATSUYAMA R, Maeda K, Yamanaka Y, Ishida Y, et al
    Assessing skeletal muscle mass based on the cross-sectional area of muscles at the 12th thoracic vertebra level on computed tomography in patients with oral squamous cell carcinoma.
    Oral Oncol. 2021;113:105126.
    PubMed     Abstract available


  607. CARNEVALE C, Ortiz-Gonzalez I, Ortiz-Gonzalez A, Bodi-Blanes L, et al
    Early T1-T2 stage p16+ oropharyngeal tumours. Role of upfront transoral robotic surgery in de-escalation treatment strategies. A review of the current literature.
    Oral Oncol. 2021;113:105111.
    PubMed     Abstract available


  608. ROY P, Mallick I, Arun I, Zameer L, et al
    Nodal yield and topography of nodal metastases from oral cavity squamous cell carcinoma - An audit of 1004 cases undergoing primary surgical resection.
    Oral Oncol. 2021;113:105115.
    PubMed     Abstract available


  609. ADDERLEY H, Rack S, Hapuarachi B, Feeney L, et al
    The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinoma.
    Oral Oncol. 2021;113:105095.
    PubMed     Abstract available


  610. KERAWALA CJ, Riva F, Paleri V
    The impact of early oral feeding following head and neck free flap reconstruction on complications and length of stay.
    Oral Oncol. 2021;113:105094.
    PubMed     Abstract available


  611. SAKTHIVEL P, Panda S, Singh CA, Rajeshwari M, et al
    T4a in 8th AJCC tongue cancers - A non-existent entity in surgical practice!
    Oral Oncol. 2021;113:105051.
    PubMed    


  612. HEFT NEAL ME, Gao RW, Brennan JR, Haring CT, et al
    Functional outcomes and tracheostomy dependence following salvage oropharyngeal surgery.
    Oral Oncol. 2021;113:105034.
    PubMed    


  613. TERENZI V, Battisti A, Della Monaca M, Priore P, et al
    Management of a rare case of squamous cell carcinoma of the tongue in a patient affected by progeria.
    Oral Oncol. 2021;113:105032.
    PubMed    


    January 2021
  614. PILAR A, Yu E, Su J, O'Sullivan B, et al
    Prognostic value of clinical and radiologic extranodal extension and their role in the 8th edition TNM cN classification for HPV-negative oropharyngeal carcinoma.
    Oral Oncol. 2021;114:105167.
    PubMed     Abstract available


  615. YILMAZ E, Ozbun MA, Gan GN
    Molecular and immune signature of HPV-positive oral cavity squamous cell carcinoma.
    Oral Oncol. 2021 Jan 25:105175. doi: 10.1016/j.oraloncology.2020.105175.
    PubMed    


  616. BHATTASALI O, Torres FA, Kang HK, Thompson LDR, et al
    Prognostic impact of retropharyngeal lymphadenopathy in early-stage HPV-associated oropharyngeal cancer: Implications for staging optimization.
    Oral Oncol. 2021;114:105147.
    PubMed    


  617. BURTNESS B, Ge J
    Reply to "Keynote 48: Is it really for everyone?"
    Oral Oncol. 2021;112:104983.
    PubMed    


  618. YOUSSEF MR, Reisner ASC, Attia AS, Hussein MH, et al
    Obesity and the prevention of thyroid cancer: Impact of body mass index and weight change on developing thyroid cancer - Pooled results of 24 million cohorts.
    Oral Oncol. 2021;112:105085.
    PubMed     Abstract available


  619. SHER DJ, Yan J, Day AT, Khan S, et al
    Comparative cost analysis between definitive radiotherapy and transoral surgery for oropharyngeal squamous cell carcinoma: A SEER-Medicare analysis.
    Oral Oncol. 2021;112:105029.
    PubMed     Abstract available


  620. WANG D, Lu Y, Nannapaneni S, Griffith CC, et al
    Combinatorial approaches targeting the EGFR family and c-Met in SCCHN.
    Oral Oncol. 2021;112:105074.
    PubMed     Abstract available


  621. LOMBARDI D, Tomasoni M, Paderno A, Mattavelli D, et al
    The impact of nodal status in major salivary gland carcinoma: A multicenter experience and proposal of a novel N-classification.
    Oral Oncol. 2021;112:105076.
    PubMed     Abstract available


  622. WINDON MJ, Le D, D'Souza G, Bigelow E, et al
    Treatment decision-making among patients with oropharyngeal squamous cell cancer: A qualitative study.
    Oral Oncol. 2021;112:105044.
    PubMed     Abstract available


  623. ALVES A, Diel L, Ramos G, Pinto A, et al
    Tumor microenvironment and Oral Squamous Cell Carcinoma: A crosstalk between the inflammatory state and tumor cell migration.
    Oral Oncol. 2021;112:105038.
    PubMed     Abstract available


  624. BARROS DE OLIVEIRA A, Morandin Ferrisse T, Albergoni Silveira H, Vilela Silva E, et al
    Intraoral atypical lentiginous melanocytic lesion in a pediatric patient.
    Oral Oncol. 2021;112:105017.
    PubMed     Abstract available


  625. NOGAL P, Bartkowiak E, Iwanik K, Wierzbicka M, et al
    Common sense and tumor treatment. A case of pilomatrical carcinoma in a 21-year-old patient with surprisingly rapid tumor progression.
    Oral Oncol. 2021;112:105007.
    PubMed     Abstract available


  626. FLUKES S, Lohia S, Barker CA, Cracchiolo JR, et al
    Are our patients doing better? A single institution experience of an evolving management paradigm for sinonasal mucosal melanoma.
    Oral Oncol. 2021;112:105006.
    PubMed    


  627. BHORIWAL S, Sharma J, Dhall K, Mandal A, et al
    Duplication of the internal jugular vein - A rare anatomical variation.
    Oral Oncol. 2021;112:104985.
    PubMed    


  628. MANTSOPOULOS K, Iro H
    Tumour spillage of the pleomorphic adenoma of the parotid gland: A proposal for intraoperative measures.
    Oral Oncol. 2021;112:104986.
    PubMed     Abstract available


    December 2020
  629. CHRISTOPHERSON KM, Moreno AC, Elgohari B, Gross N, et al
    Outcomes after salvage for HPV-positive recurrent oropharyngeal cancer treated with primary radiation.
    Oral Oncol. 2020;113:105125.
    PubMed     Abstract available


    October 2020
  630. FLEMING CW, Ward MC, Woody NM, Joshi NP, et al
    Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial design.
    Oral Oncol. 2020;112:105046.
    PubMed     Abstract available


  631. MILLIET F, Bozec A, Schiappa R, Viotti J, et al
    Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric study.
    Oral Oncol. 2020;112:105041.
    PubMed     Abstract available


  632. CONTRERA KJ, Smile TD, Mahomva C, Wei W, et al
    Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 staging.
    Oral Oncol. 2020;111:105030.
    PubMed     Abstract available


    August 2020
  633. FAKHRY C, Fung N, Tewari SR, D'Souza G, et al
    Unique role of HPV16 in predicting oropharyngeal cancer risk more than other oncogenic oral HPV infections.
    Oral Oncol. 2020 Aug 29:104981. doi: 10.1016/j.oraloncology.2020.104981.
    PubMed    


    July 2020
  634. HSU AC, Kokot NC, Eisenberg BL, Thomas JS, et al
    Complete response with talimogene laherparepvec in recurrent melanoma of the ear: A case report.
    Oral Oncol. 2020 Jul 11:104899. doi: 10.1016/j.oraloncology.2020.104899.
    PubMed     Abstract available


    June 2020
  635. KREIMER AR, Chaturvedi AK, Alemany L, Anantharaman D, et al
    Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI.
    Oral Oncol. 2020;108:104736.
    PubMed     Abstract available


    May 2020
  636. JOO YH, Cho KJ, Kim GJ, Kim MS, et al
    Prognostic impact of resection margin involvement in surgically managed HPV-positive tonsil cancer.
    Oral Oncol. 2020;108:104806.
    PubMed     Abstract available


  637. KYLMA AK, Jouhi L, Mohamed H, Randen-Brady R, et al
    In HPV-negative oropharyngeal squamous cell carcinoma, elevated toll-like receptor 2 immunoexpression may increase the risk of disease-specific mortality.
    Oral Oncol. 2020;107:104778.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: